Next Article in Journal
The Role of Polymorphism in the Endothelial Homeostasis and Vitamin D Metabolism Genes in the Severity of Coronary Artery Disease
Previous Article in Journal
Changes in Molar Tipping and Surrounding Alveolar Bone with Different Designs of Skeletal Maxillary Expanders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters

1
Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland
2
Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, al. Powstancow Wlkp. 72, 70-111 Szczecin, Poland
3
Department of Toxicology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland
*
Author to whom correspondence should be addressed.
Biomedicines 2023, 11(9), 2381; https://doi.org/10.3390/biomedicines11092381
Submission received: 20 June 2023 / Revised: 10 August 2023 / Accepted: 16 August 2023 / Published: 25 August 2023
(This article belongs to the Special Issue Immunomodulatory Potential of Essential Oils and Their Compounds)

Abstract

:
Efficient functionality of the immune system is needed to fight against the development of infectious diseases, including, among others, serious recurrent chronic infections. Research has shown that many modern common diseases, such as inflammatory bowel diseases and cardiovascular diseases, e.g., thromboembolism, cancer, obesity, or depression, are connected with inflammatory processes. Therefore, new, good stimulators of the immune system’s response are sought. They include synthetic compounds as well as biological preparations such as lipopolysaccharides, enzymes, bacterial metabolites, and secondary metabolites of plants, demonstrating a multidirectional effect. Essential oils are characterized by many invaluable activities, including antimicrobial, antioxidant, anti-inflammatory, and immunostimulating. Essential oils may stimulate the immune system via the utilization of their constituents, such as antibodies, cytokines, and dendritic cells. Some essential oils may stimulate the proliferation of immune-competent cells, including polymorphonuclear leukocytes, macrophages, dendritic cells, natural killer cells, and B and T lymphocytes. This review is focused on the ability of essential oils to affect the immune system. It is also possible that essential oil components positively interact with recommended anti-inflammatory and antimicrobial drugs. Thus, there is a need to explore possible synergies between essential oils and their active ingredients for medical use.

1. Introduction

Proper functioning of the immune system is a key factor in the prevention and treatment of many different diseases, e.g., infections and cancers. Adverse effects of antibiotics and their bacterial resistance have prompted researchers to attempt to influence the host immune response to an infection using compounds demonstrating immunomodulatory properties, called biological response modifiers (BRM). These substances may affect certain immune mechanisms either as immunostimulators or immunosuppressants [1].
Nowadays, most available substances that might affect the human immune system are of natural origin. For instance, in lipopolysaccharide (LPS), many different enzymes and metabolites are isolated from bacteria, while secondary metabolites, commonly used in the production of immunoboosters, are mostly extracted from plants. Also, products made by animals, e.g., reptile venom, may be utilized. In recent years, compounds derived from medicinal plants have appeared to be highly interesting immunomodulators [1]. Essential oils, characterized by a wide spectrum of health-supporting activity, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory properties, make up a particularly interesting group of herbal metabolites.

2. Action of the Human Immune System

The principal role of the immune system is to protect the host from outside distress, e.g., pathogens. Its activity comprises two variants of systems: innate and adaptive immunity [2]. The innate immune system acts as the first line of response and is responsible for an adequate reaction to injury. Its rapidity is a key factor in the elimination of the transmission of pathogens through their recognition, internalization into phagocytes, and digestion. This process engages receptors called pattern recognition receptors (PRRs), responsible for the recognition of specific structures of microorganisms, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) [3]. During the next step, several types of cytokines, e.g., interleukin 1 (IL-1), IL-6, IL-8, and tumor necrosis factor (TNF), stimulate neighboring cells [4] to secrete chemokines to begin the inflammatory response [5]. Also, activation of lymphocytes may be related to inflammatory processes [5,6]. IL-6, which plays a role in the differentiation of B cells, stimulation of immunoglobulin production, induction of the acute phase response, and stimulation of inflammatory processes, is one of the most important cytokines involved in the host defense system as it demonstrates a broad spectrum of immune and hematopoietic properties. Also, IL-8 (a chemokine called C-X-C motif ligand 8; CXCL8) is involved in the immunological response via induction of chemotaxis in target cells and stimulation of phagocytosis [5,7]. TNF (the inflammatory cytokine) is generated by macrophages or monocytes during acute inflammation processes that lead to necrosis or apoptosis [8]. It is also involved in leukocyte adhesion, the control of blood coagulation, and the indirect induction of fever [9,10].
Secretion of inflammatory mediators takes place via proteins called Toll-like receptors (TLRs) and leads to the maturation of dendritic cells and phagocytes involved in tissue homeostasis, which may prime the adaptive immune response during the next step by inducing T cell maturation and T helper type 1 (Th1) polarization [11,12].
The adaptive immune system provides a delayed but definitely more specific response. It generates and retains memory and comprises humoral and cell-mediated responses, in which two types of cells are involved: T and B cells. Antigen-presenting cells stimulate these cells upon recognizing either free antigen or bound antigen. Activated B cells produce antibodies, which are responsible for, e.g., toxin inactivation, bacterial opsonization, pathogen fagocytosis, and activation of the complement system. Five classes of antibodies are produced: IgM, IgG, IgE, IgA, and IgD. For instance, IgM and IgG immunoglobulins, which are present in the blood serum, are involved in recognizing and binding to specific antigens–pathogens and toxins, hereby taking part in their destruction or elimination [13]. They may also play a role as antigen-presenting cells, e.g., for a primed specific T cell, or be involved in cytokine production [14], while T cells produce cytokines responsible for B cell division and differentiation into a mature, antibody-producing plasma cell [15].

3. Influence of the Immune System on Wound Healing

According to professional literature, 1 in 10 diabetic patients worldwide is affected by major complications related to chronic non-healing wounds [16]. Chronic non-healing wounds, e.g., those that affect diabetic patients, increase the risk of infection [17].
Our skin is protected from unwanted external conditions, e.g., microbes, chemicals, and injuries. Inflammation of the wound is a host response to microorganisms that damage viable host tissue, thereby affecting the wound healing process. Inflammation is supposed to eliminate or at least reduce unwanted changes made by an injurious agent. The innate and adaptive immune systems are important regulators of processes involved in wound healing through the promotion of cellular cross-talk and the secretion of signaling molecules, e.g., cytokines, chemokines, and growth factors. It has to be noted that epithelium not only serves as the body’s first-line mechanical barrier but is also a part of innate immunity processes, e.g., being a regulator of inflammation via expression of chemotactic agents of human cathelicidin LL-37 in keratinocytes during skin inflammation and being a promoter of resistance to skin infections by the production of antimicrobial peptides (AMPs) [18,19]. The relationship between epithelial regeneration and AMP production has been proven. Some types of AMPs promote wound-edge keratinocyte proliferation and migration [20]. Additionally, keratinocytes express proteins called TLRs, which are involved in the production of cytokines and chemokines [5]. There are many different types of TLRs expressed throughout the normal human epidermis, but TLR4 is specifically needed in early skin wound healing [21]. TLR activation may affect wound healing in a dose-dependent manner, as it may suppress growth at higher concentrations but promote regeneration at lower concentrations [22].
Various immune cells take part in the maintenance of homeostasis in healthy skin. Dendritic cells, macrophages, T cells, and neutrophils are all involved in wound healing [16]. In acute infections, interleukins are secreted into blood vessels from local tissue sites [7]. It is well documented that T cells may affect the wound environment in different ways as they secrete several types of cytokines. T lymphocytes play a role in the production of growth factors and as immunological effector cells during wound healing [23]. Both innate and adaptive responses are needed for cutaneous immunosurveillance and wound healing [15,24]. Acute wound healing includes the production of specific signaling molecules, cytokines, chemokines, and growth factors. It is noteworthy that overproduction of cytokines and proteases results in persistent inflammation, thus affecting wound healing. Therefore, the immune processes must be monitored to ensure successful wound healing [24].
Neutrophils, which belong to the innate immune response, play a role in both acute and hard-to-heal wound inflammation. In acute infections, they lead to the phagocytosis of invading microorganisms by the secretion of extracellular traps (NETs), which capture and inactivate bacteria [25]. The situation becomes more complicated when microbes are able to produce biofilm. It has been proven that a chronic biofilm infection is related to a permanent and lower-grade host inflammatory response (lower levels of IL-1β and TNF expression) when compared with an infection of acute wounds [26]. Additionally, Moser et al. proved that the persistent inflammatory response may lead to host tissue damage, fibroblast senescence, and inhibited secretion of growth factors required for wound healing if the innate host immune system is not able to eradicate biofilm. Therefore, fighting wound biofilm, which occurs during chronic infection, involves an additional step in the immune response. At the beginning of an infection, neutrophils are recruited similarly as in the event of an acute infection, but in the process of biofilm maturation, pro-inflammatory cytokines, e.g., interleukins and TNF, are produced. This step takes place when the host’s response becomes overwhelmed. It prevents continuous oxidative stress, supports the production of growth factors, and generally controls infection [27,28].

4. Influence of Selected Essential Oils on the Immune System

According to the World Health Organization (WHO, Geneva, Switzerland), over 60% of the world’s population confirms the therapeutic effect of folk medicine [29]. Many different scientific articles indicate that herbs used in traditional medicine contain various compounds demonstrating biological and therapeutic activities [30]. Many plants produce essential oils when subjected to stressful conditions. Essential oils have a wide range of health promoting properties, and they are also highly safe due to their low toxicity and minor side effects.
Essential oils are complex mixtures extracted from different parts of plants (stem, flowers, or leaves) through steam distillation or the use of specific solvents that have been used in traditional medicine for ages [31]. The most known application of essential oils, i.e., aromatherapy, may successfully improve the quality of life of patients suffering from serious diseases, such as cancer, as it reduces anxiety and pain [32,33].
The biological activity of essential oils is mainly a result of the activity of their constituents through synergistic or antagonistic effects [34]. Essential oils may also stimulate the immune system and thus become an alternative to conventional treatment of many different diseases and other health problems, e.g., cancer, allergies, wounds, and inflammatory diseases [35], via the utilization of constituents of the immune system, such as antibodies, cytokines, and dendritic cells [36,37]. Some essential oils may stimulate the proliferation of immune-competent cells, including polymorphonuclear leukocytes, macrophages, dendritic cells, natural killer cells, and B and T lymphocytes [38,39]. For instance, constituents of essential oils produced by Eucalyptus stimulate phagocytosis by macrophages [40], while Nigella sativa essential oil stops the proliferation of CD4+ and CD8+ lymphocytes in vitro [41].
Therefore, together with their constituents, they are considered promising therapeutic agents, which could be an alternative/support to currently used antibiotics and other drugs [42]. According to professional literature reports, essential oils may display similar or even greater immunomodulatory properties compared to conventional drugs [43,44]. Yet it has to be kept in mind that essential oils, if used improperly, might have some side effects. However, they are not cytotoxic if used at low concentrations [39,45].
This review summarizes a literature-based search focused on the abilities of essential oils to affect the immune system. By searching the keywords “immune system and essential oil”, “immune response and essential oil”, “essential oil and inflammation”, and “essential oil and wound” in PubMed, Web of Science, and Science Direct, we screened out articles with high correlation based on the influence of essential oils on the human immune system and their potential application as immunomodulators of this system. We decided to exclude studies focused on the influence of Eos on animal immune systems for veterinary purposes. Due to the fact that a very good review related to the application of essential oils in immunology was published in 2019 [46] and a lot of new interesting data related to this subject were also published, we decided to analyze the research reports that have been published within the last 5 years. Here, we would like to present an overview of the biological properties of essential oils produced by plants that we regard as interesting, giving special consideration to their immunomodulatory and anti-inflammatory properties (Figure 1). The detailed composition of all essential oils discussed in this manuscript and a summary of their influence on the immune system (activity) are presented in Table 1 at the end of the section. The influence of the most common essential oil constituents on the immune system (activity) and their chemical classification are presented in Table 2 at the end of the section.
The wild plant Myrtus communis (M. communis, myrtle) is known in traditional medicine as a remedy for stomach aches, wound healing, hemorrhoids, etc. [47], as its leaves, fruits, roots, and berries display, for example, anti-inflammatory, analgesic, antioxidant, anticancer, anti-diabetic, anti-mutagenic, and neuro-protective activity [48]. It releases essential oils whose insecticidal, antioxidant, anti-inflammatory, antibacterial (against Staphylococcus aureus, Listeria monocytogenes, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, etc.), antiviral (against Herpes simplex), and antifungal (against Candida spp., etc.) properties are widely used in traditional herbal medicine. These essential oils are rich in terpenes, terpenoids, and phenylpropanoids [49]. Shaapan et al. revealed the prophylactic effects of M. communis essential oils against chronic toxoplasmosis induced by the Tehran strain of Toxoplasma gondii in mice. According to the literature, toxoplasmosis is controlled by cellular immunity, so the authors evaluated the effect of the tested myrtus oil on chosen innate immunity mediators such as interferon gamma (IFN-γ) and IL-12 [50]. IL-12 and IFN-γ. All of these are involved in the control of the synthesis of nitric oxide, which is the initial effector in the immune system response against toxoplasmosis [51]. The studies showed that the IFN-γ and IL-12 mRNA levels were significantly higher in mice treated with essential oils when compared to the control groups. Mahmoudvand et al. proved that the mentioned essential oil is not significantly toxic at doses up to 0.4 mL/kg to BALB/c mice when administered orally for 14 days [52]. However, further, more advanced studies on the choice of optimal concentrations, the most active fraction or extracts, the mechanism of action, and pharmacokinetics are still needed [53,54,55].
Shin et al. explored the immunomodulatory effects of essential oils extracted from Chamaecyparis obtusa on house dust mite-induced mucosal inflammation. Chamaecyparis obtusa (C. obtuse, Cupressaceae) is a species of cypress commonly found in the southern part of Korea and central Japan that produces essential oils containing, e.g., monoterpenes, sesquiterpene hydrocarbons, and oxygenated sesquiterpenes. It also possesses antibacterial, antiatopic, and anti-inflammatory properties [56]. The mentioned essential oil significantly suppresses the secretion of IL-25 and IL-33 from epithelial cells (critical regulators of Th2 immune responses), which may occur as a response to allergens related to the development of airway allergic inflammation, in a dose-dependent manner [57,58]. It also controls prostaglandins (PGs) and TNF gene expression, thus blocking LPS-induced inflammation as well as the expression and activity of nuclear-kappa B factor (NF-κB) and activator protein 1 (AP-1), leading to inhibited production of IL-6 and IL-8 from bronchial epithelial cells [48]. Thus, it may affect innate and adaptive immune responses involved in the inflammation process. It is noteworthy that a concentration of essential oil lower than 0.1% did not affect the viability of nasal epithelial cells treated with allergens related to the development of airway allergic inflammation, and according to some authors, plain oil extracted from C. obtusa was approximately 10 times more toxic to nasal epithelial cells than its microencapsulated form [59].
Nigella sativa (N. sativa, Ranunculaceae) produces seeds known as black cumin, Haba al-Barakah (blessed seeds), or miracle herb. The seeds were called “herbs from heaven” by ancient herbalists [60,61]. Its beneficial properties have been used widely all over the world in traditional medicine, for example, in Unani, Ayurveda, Tibb, and Siddha cultures for a long time in therapies for many different diseases such as asthma, bronchitis, rheumatism, headache, back pain, paralysis, inflammation, and hypertension [62]. It contains many different compounds that are able to inhibit chronic inflammation and stimulate a healthy immune response. Additionally, they may affect autophagy dysfunction, oxidative stress, ischemia, inflammation, and bacterial and viral infections. Moreover, topical application of this essential oil showed an antiseptic and local anesthetic effect, as well as helping to get rid of skin blisters and eczema [63]. Its main constituents are nigellone, thymoquinone, thymohydroquinone, dithymoquinone, thymol, carvacrol, α- and β-pinene, d-limonene, d-citronellol, p-cymene, carvacrol, trans-anethole, 4-terpineol, longifolene, and α-hederin [61,64]. The most biologically active element is thymoquinone. According to literature reports, it is responsible for the majority of the above-mentioned properties of cumin essential oil, and its antioxidant, anticancer, and antibacterial properties were confirmed in numerous studies [65,66,67,68,69,70,71,72]. Several studies on animal models proved that the essential oil isolated from black cumin also exhibits good anti-inflammatory activity related to the presence of thymoquinone [73]. Hossen et al. proved that it affects the activity of pro-inflammatory factors (TNF, IL-6, and IL-1β) in LPS-stimulated murine macrophage-like RAW264.7 cells [74]. Additionally, Ebrahimi et al. proved that α-hederin administered at a concentration of 0.02 mg/kg in ovalbumin (OVA)-sensitized rats, as in the asthma model, has an influence on IL-2 and IL-17 secretion pathways, changing miRNA-133a expression [71,75]. It should be pointed out that freshly extracted essential oil reduced the IL-6 level in human pre-adipocytes with low-grade inflammation, while stored oil decreased the IL-1β level [76]. At a concentration of 400 mg/kg, it also changed the level of pro-inflammatory cytokines (IL-6, IL-12, and TNF) in paw exudates and sera in rats with carrageenan-induced paw edema [77]. Moreover, external application of a balm stick containing 10% essential oil in rats with paw edema inhibits edema (60.64%), reduces leukocyte count (43.55% lower than control), and lowers TNF level (50% lower than control), thereby significantly reducing acute and sub-acute inflammation at the inflammation site [73]. Its ability to suppress inflammation is related to the activation of anti-inflammatory signaling pathways (NF-κB and TLR signaling). It can stimulate immunity via one of several pathways: 1. modulation of innate as well as adaptive immune components; 2. prevention of apoptosis by upregulation of pro-survival signals and downregulation of pro-apoptotic signals (PI3K/Akt, JNK, and mTOR); 3. induction of autophagy (silent mating type information regulation 2 homologue 1 [SIRT1] signaling); 4. priming of energy metabolism (AMPK-SIRT1-PGC-1α and PPARγ signaling); 5. stimulation of the growth factor pathway (PI3K/Akt signaling); 6. upregulation of lipoprotein receptor-related protein 1 (LRP1), which leads to protein clearance [78].
Moreover, it has been documented that cumin essential oil reduces the inflammation process in LPS/IFN-γ or H2O2-activated BV-2 microglial cells by reducing the level of cytokine (IL-2, IL-4, IL-6, IL-10, and IL-17a) and chemokine (CXCL3 and C-C motif ligand 5 [CCL5]) expression, thus protecting against neuroinflammation related to Alzheimer’s disease [79]. It may also protect from neuroinflammation by inducing autophagy via activation and nuclear accumulation of SIRT1 in LPS-activated BV-2 microglia [80]. Moreover, by downregulating the expression of TLR signaling components and their downstream NF-κB effectors and interferon regulatory factor 3 (IRF-3), cumin essential oil increases inflammation processes in the Alzheimer’s disease model [81].
Also, a few preclinical and clinical studies revealed the immunomodulatory properties of black cumin. For instance, Sheik et al. proved that an ethanolic extract of black cumin increases the macrophage population of the murine cell line J774A.1 [82] and supports the phagocytic properties of several different macrophage populations [83]. Koshak et al. confirmed that the essential oil extract supports the immune response by reducing IL-2, IL-6, and prostaglandin E2 (PGE2) in primary T-lymphocytes and IL-6 and PGE2 in primary monocytes, which are asthma-related inflammatory mediators [84]. It can also activate macrophages and sustain the total number of leukocytes, neutrophils, eosinophils, basophils, lymphocytes, and monocytes in Salmonella Typhimurium-infected rats [85].
Interestingly, black cumin and its constituents improve the anticancer activity of other recommended chemotherapeutic and natural compounds that are able to prevent cancer. For instance, when applied together with 5-fluorouracil at a concentration of 35 mg/kg/day, p.o., 3 days/week for 9 weeks, they improved its cytotoxicity in AOM-instigated colon cancer rats by reducing NF-κB expression [86]. An application of black cumin at a concentration of 10 mg/kg/day; i.p. for 14 days in combination with piperine significantly diminishes tumor size and leads to apoptosis via downregulation of vascular endothelial growth factor (VEGF) and improvement of IFN-γ and IL-2 levels [78,87].
Houttuynia cordata Thunb. (H. cordata; Saururaceae) is a widely grown plant in Asia and commonly used in folk medicine due to its biological activity. For instance, in China, it has been used as a remedy for pneumonia and lung abscesses for ages. It might be applied in combination with other medicines against dysentery, colds, fevers, and mumps. Nowadays, it is still eaten and applied in traditional medicine, for instance, in the Yarlung Zangbo Valley in Assam, India [88]. Its wide spectrum of biological activity is attributed to the presence of flavonoids and essential oils. The main constituents of the essential oil are monoterpenes, sesquiterpenes and their oxides, oxidized diterpenes and phenylpropene derivatives, nonyl ketones (2.10–40.36%), bornyl acetate (0.4–8.61%), and β-myrcene (2.58–18.47%), but their composition differs between the aboveground and underground parts of the plant [89,90]. Aboveground parts, rather than underground elements, contain a concentration of 2-undecanone, myrcene, ethyl decanoate, ethyl dodecanoate, 2-tridecanone, and decanal. Differences observed in the antibacterial activity of essential oils isolated from chosen parts of H. cordata by some researchers relate to the composition of particular parts of this plant [91]. According to literature reports, the plant is able to decrease the secretion of inflammatory factors, thereby moderating lung injury and rheumatoid arthritis. In addition, it may strengthen the immune barriers of the vagina, oral cavity, and intestinal tract against pathogen infection. It is able to alleviate the pathological influence of bleomycin on lung tissue [92] by upregulating IFN-γ levels and inhibiting the transforming growth factor β1 (TGF-β1)/Smad signaling pathway in mice [93,94].
Thymus vulgaris L. (T. vulgaris) is another herb that produces biologically active essential oil. According to professional literature, it possesses a wide spectrum of properties, e.g., antioxidant, antibacterial, antispasmodic, anthelmintic, immunomodulatory, anti-inflammatory, and antiseptic [43]. These activities are attributed to its constituents, such as thymol and eugenol, which are phenolic compounds. It must also be taken into account that the amount of constituents and especially active ingredients in T. vulgaris oil may vary depending on environmental conditions, plant harvesting seasons, and the geographical area [43]. The anti-inflammatory activity of essential oil extracted from T. vulgaris is probably related to its capability to diminish the production of proinflammatory cytokines [95]. Ocaña et al. proved that T. vulgaris EO is able to elevate inflammation via reduced secretion of inflammatory mediators such as TNF, IL-1β, C-reactive protein (CRP), and IL-8, as well as an increase in anti-inflammatory mediators such as IL-10 production processes [96]. Major constituents of essential oils involved in this process seem to be thymol, which affects the properties of an inflammatory process marker called elastase, produced by activated neutrophils, and inhibits cyclooxygenase (COX), as well as p-cymene, which inhibits NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways and affects TNF and IL-1β secretion [97,98]. It is also noteworthy that thymol and carvacrol are able to suppress the activity of transcription factors responsible for the initiation of cytokine expression in T cells, including AP-1 and nuclear factors of activated T cells (NFAT). It is also able to arrest the production of IL-2 and IFN-γ, thus affecting T cell activation [99]. Ismail et al. observed that application of essential oil from T. vulgaris to animals affected by E. coli O157:H7 significantly diminished serum IL-6, IL-8, and TNF concentrations when compared to the control group [8,100]. As literature reports show, thyme essential oil may also affect the synthesis of LPS-mediated nitric oxide and IFN-γ [8,101]. This observation is also worth stressing.
Also, Artemisia judaica L. (A. judaica), a perennial plant from the Asteraceae (Compositae) family, is commonly used due to its pro-health properties [8]. It commonly grows in the Mediterranean region, including Algeria, Libya, Egypt, Jordan, and Saudi Arabia [10,102,103]. It is famous for its anticancer, antimicrobial, antiviral, antidiabetic, antioxidant, hepatoprotective, and anti-inflammatory activities. Its application to hyperglycemia, heart diseases, inflammatory disorders, and arthritis is known in traditional medicine [102,104]. Moreover, it is able to improve vision and the immune system [105,106]. It produces essential oils, which contain, e.g., monoterpenes and cinnamic acid derivatives, known for their excellent antioxidant properties in vitro and in vivo. Hamdoon et al., among other authors, noted that they can reduce TNF and promote pro-angiogenic/anti-inflammatory TGF-β1, which is involved in wound healing, angiogenesis, immune regulation, and cancer. However, it has to be pointed out that an application of this essential oil did not affect IL-1b and IL-6, which help TGF-β1 in Th17 differentiation, aggravating inflammation. Additionally, the level of IL-10, a regulator of the immune response that limits the inflammatory process, was also promoted in wound healing tissue when essential oil was applied [9,107,108].
The anti-inflammatory as well as antioxidant activity of A. judaica essential oil is related to the presence of oxygenated monoterpenes [9] known for their involvement in wound healing: thujone, 1,8-cineole, camphor, borneol, and methyl cinnamate. Moreover, 1,8-cineole suppresses the inflammatory markers TNF, IL-6, IL-8, leukotriene B4 (LTB4), PGE 2, and IL-1; it also downregulates 5-lipoxygenase (LOX) and COX [10,109,110].
Patchouli (Pogostemon cablin, P. cablin) essential oil has been known for its healing properties since ancient Egyptian times. It is noteworthy that it is able to differ M1 to M2 macrophage phenotypes and change the inflammatory milieu of ApcMin/+ mice, inhibit CD4+CD25+, and stimulate CD4+ and CD8+ cells in the spleen, blood, mesenteric lymph nodes (MLNs), and Peyer’s patches (PPs) of treated mice [111].
Echinacea purpurea (E. purpurea) L. Moench (Asteraceae) is widely known in the United States, Canada, and Europe for its medicinal properties. E. purpurea, E. angustifolia, and E. pallida are the most known biologically active species from the Echinacea genus [112]. The main elements of the essential oil extracted from Echinacea are terpenes, such as germacrene D, polyacetylenes, highly unsaturated alkamides, and phenolic compounds [113,114]. According to literature reports, it helps in wound healing, supports the immune system, and diminishes respiratory problems caused by bacterial infections. It is postulated that its antimicrobial and immunomodulatory properties may be linked to each other due to synergistic effects on the host immune system. Echinacea may affect the immune system by stimulating monocytes and natural killer cells [112,114,115].
Cardamom (Elettaria cardamomum Maton, Zingiberaceae) is a perennial herb commonly used as a spice in traditional Indian cuisine. It is called “the Queen of Spices”, as it is listed as the third most precious spice after saffron and vanilla [116]. Its essential oils are known in folk medicine and are applied in the treatment of colds, bronchitis, and asthma [117]. The anti-oxidant, anti-inflammatory, anti-microbial, and anti-cancerogenic properties of essential oils result from the biological activity of phenolic compounds [118,119,120].
An immune-competent patient affected by Camphylobacter spp. requires only symptomatic treatment and fluid and electrolyte replenishment, whereas an immune-compromised patient should usually be administered antibiotic treatment with macrolides or fluoroquinolones. Additionally, in some rare cases, post-infectious autoimmune diseases like chronic inflammatory bowel diseases may occur [121].
Heimesaat noted that application of cardamom essential oil to mice suffering from acute C. jejuni-induced enterocolitis (C. jejuni-infected microbiota-depleted IL-10/ mice) may induce an anti-pathogenic and immune-modulatory effect by reduction of pro-inflammatory mediator secretion in the intestinal tract, extra-intestinal, and systemic compartments and by general improvement of clinical outcome during acute campylobacteriosis. These beneficial effects may be observed at least one day following the commencement of the treatment (i.e., day 3 p.i.). However, it should be kept in mind that these results might be, at least partly, related to the antimicrobial activity of applied cardamom [122,123,124]. A diminishing pro-inflammatory immune response during C. jejuni infection in IL-10/ mice is related to a reduced number of macrophages, monocytes, and T lymphocytes in the colonic mucosa and lamina propria and a lower secretion of nitric oxide, TNF, and IFN-γ in the intestinal tract. Additionally, in vitro studies showed that cardamom suppresses the secretion of Th1 cytokines, including IFN-γ [125], in murine splenocytes, which also appeared to be true for nitric oxide and TNF production by mouse peritoneal macrophages [125]. It is noteworthy that suppression of inflammatory processes in alveolar macrophages in vitro is related to the activity of 1,8-cineole, i.e., the main constituent of essential oil [124,126].
Also, essential oil extracted from the peel of the Citrus sudachi (sudachi oil, Rutaceae) plant is able to suppress antigen-induced lymphocyte activation as well as the properties of antigen-presentation-related molecules on dendritic cells in vitro. Sudachi oil also suppresses antigen-specific T cell induction in vivo in mice immunized with OVA [127].
Euodia ruticarpa (E. ruticarpia) (Rutaceae), also known as Tetradium ruticarpum, but especially its fruit, called Tetradii fructus, Evodiae fructus, or Wu Zhu Yu, is commonly applied in traditional as well as clinical medicine in East Asia, e.g., in Korea, Japan, and China, due to a great variety of health benefits, e.g., anti-inflammatory and anti-cancer properties. It has been used to treat post-eating nausea, vomiting, diarrhea, abdominal pain, headache, pelvic inflammation, or bacterial infections [32,128,129]. According to Yeh et al., the main constituents of steam-distilled essential oil, such as 2-(3-methoxyphenyl)-4H-1-benzopyran-4-one, N,N′-diphenyl-1,4-benzenediamine, benzoic acid, N-propylbenzamide, and dipropylene glycol dibenzoate, are responsible for E. ruticarpa’s anti-cancer properties. They are able to inhibit the PC-3 prostate cancer cell line by regulating Th1 (IL-2) and Th2 (IL-10) cytokine production by splenocytes (the spleen is strictly involved in immunological processes in the human body) [130]. Furthermore, the levels of IL-1β, TNF, IL-6, and IL-10 secreted by macrophages increased. Considering the fact that synergistic interactions of IL-2 and IL-10 cytokines advance the CD8+ T cell cytotoxic effect, the authors concluded that the essential oil is able to support anti-cancer immunity. It may also activate natural killer (NK) cells and B cells, generating even better anti-cancer results [131,132,133]. According to Tahvildari et al., IL-2 treatment seems to be a promising direction to combat both autoimmune and inflammatory diseases. Moreover, it has been approved by the US Food and Drug Administration for the treatment of cancer. The PC-3 cell line is hormonally independent, so traditional hormonal therapy cannot be applied. In this case, an alternative therapy that fights cancer indirectly via immune cells might be invaluable [32,134,135].
The Eucalyptus plant (Myrtaceae), used by Australian Aboriginals in the treatment of inflammation and wound infections, is one of the most known herbs that is able to produce essential oil [136]. Nowadays, it is also used as a support in the therapy of infectious and respiratory diseases [137,138]. Its main constituent, 1,8-cineole (also known as eucalyptol), as well as terpenes such α-pinene and limonene, are characterized by a wide spectrum of biological activities [139,140]. For instance, its topical application inhibits edema and enhances vascular permeability in IgE-mediated allergic dermatitis. It may also stimulate the immune system, e.g., the immune function of the respiratory tract. It can also be used as an adjuvant in some infections and inflammatory diseases. This essential oil is able to stimulate monocyte-derived macrophage (MDM) activity in vitro [40,141,142]. According to Zonfrillo et al., it seems to improve the digestion process of microbial agents, e.g., the phagocytosis of zymosan particles by macrophages. Hence, it might be used as an adjuvant in the treatment of infectious and immunosuppressive diseases. It is noteworthy that pathogen internalization in this process takes place via stimulation of complement receptor (CR)-mediated phagocytosis soon after exposure to foreign microorganisms, which means that essential oils may affect the innate immune system already at the early stages of pathogen infection. It is known that this property of essential oils is attributed to the presence of eucalyptol. Nevertheless, further studies on this process are needed. The mentioned essential oil might also increase podosome density as well as augment colocalization at the podosomes of the actin core with the ring component vinculin, thereby taking part in macrophage motility and chemotaxis processes. Moreover, in the initial stages of treatment, this essential oil is able to significantly stimulate expression levels of the basic structural elements of the podosome ring: αM (CD11b) and β2 (CD18) integrins, involved in control of the relation between cell and extracellular matrix in processes related to cell movement, and form together the heterodimeric complex CD11b/CD18 (or CR3) [2].
Table 1. The influence of essential oils on the immune system and their composition.
Table 1. The influence of essential oils on the immune system and their composition.
Lp.Plant SpeciesActivityMain Constituents (>1%)
(The Composition of Essential Oil May Differ Depending on e.g., a Part of the Plant, Geographical Area, Season When It Was Harvested)
(–Means Lack of the Peesence of the Component in Tested Material)
Literature Source
1.Myrtus communis
(M. communis, myrtle)
  • Increases levels of IL-12 and IFN-γ mRNA in response to toxoplasmosis.
The composition of essential oil isolated from leafs of the plant grown in Jericho/Jenin/Tunisia:
  • α-Pinene 3.95/10.22/15.59
  • o-Cymene 0.17/1.34/-
  • 1,8-Cineole 24.32/31.55/16.55
  • Linalool –/21.65/13.30
  • cis-4-Thujanol 27.37/–
  • α-Terpineol –/4.35/2.88
  • Myrtenol –/20/-
  • Myrtenal 6.78/21/-
  • Trans-4-Thujanol acetate 11.26/22/-
  • Linalyl acetate 1.04/0.42/3.67
  • Myrtenyl acetate 0.62/2.89/20.75
  • α-Terpinyl acetate 1.77/1.30/-
  • a-humulene -/-/1.29
  • limonene -/-/8.94
  • geranyl acetate -/-/2.99
  • methyleugenol -/-/1.17
[50,51,52,143,144]
2.Chamaecyparis obtusa
(C. obtuse,
Cupressaceae)
It is able to inhibit inflammatory processes by:
  • suppressing secretion of IL-25, IL-33 from epithelial cells,
  • affecting PGs and TNF gene expression
  • affects activity of NF-κB and AP-1
  • inhibiting production of IL-6, IL-8 from bronchial epithelial cells [48].
The composition of essential oils isolated from leafs of the tree grown in South Korea/from fruit of the tree grown in Sudan:
  • α-Pinene 1.85/69.1
  • sabinene 10.97/11.6
  • myrcene 3.76/1.1
  • limonene 6.89/-
  • γ-terpinene 3.13/-
  • terpinene-4-ol 4.11/-
  • isoBornyl acetate 8.85/-
  • α-terpinyl acetate 13.71/-
  • cadinene 1.57/-
  • Ceder acetate 4.25/-
  • epi-Bicyclosesqui-phellandrene 4.06/-
  • β-Cubebene 1.12/-
  • δ-Cadinene 2.95/-
  • α-Elemene 2.32/-
  • α-Cedrene 1.10/-
  • Elemol 4.62/-
  • Cedrol 1.75/-
  • α-Selinene 1.34 /-
  • β-Eudesmol 1.58/-
  • Longifolene 2.03/-
  • β-pinene -/3.1
  • δ-3-Carene -/12.1
[48,57,58,145,146]
3.Nigella sativa
(N. sativa, Ranunculaceae)
Inhibits inflammation by:
  • activating NF-κB and TLR signaling pathway
  • preventing apoptosis by upregulation of pro-survival signals and downregulation of pro-apoptotic signals (PI3K/Akt, JNK, and mTOR)
  • inducing autophagy (silent mating type information regulation 2 homologue 1 [SIRT1] signaling)
  • primes energy metabolism (AMPK-SIRT1-PGC-1α and PPARγ signaling)
  • stimulating PI3K/Akt signaling pathway
  • upregulates lipoprotein receptor-related protein 1 (LRP1)
  • affecting IL-2 and IL-17 secretion pathways, changing miRNA-133a expression in the asthma model in rats
  • affecting activity of TNF, IL-6, IL-1β in LPS-stimulated murine macrophage-like RAW264.7 cells
  • reducing IL-2, IL-6, and PGE2 in primary T-lymphocytes and IL-6 and PGE2 in primary monocytes, which are asthma-related inflammatory mediators
  • changing IL-6, IL-12, TNF levels and leukocytes count in rats with paw edema
  • reducing IL-2, IL-4, IL-6, IL-10, and IL-17a levels, as well as chemokines (CXCL3 and C-C motif ligand 5 [CCL5]) expression in the Alzheimer’s disease model
Freshly extracted oil reduces the IL-6 level in human pre-adipocyte, while stored oil decreases IL-1β level in rats with paw edema

May increase proinflamatory processess in the Alzheimer’s disease model by:
  • downregulating the expression of TLRs signaling components and their downstream effectors NF-κB and interferon regulatory factor 3 (IRF-3)

Plays a role in combating infections by:
  • sustaining the total number of leukocytes, neutrophils, eosinophils, basophils, lymphocytes, monocytes in Salmonella Typhimurium infected rats

Plays a role in anticancer treatment because:
  • in combination with piperine, it affects tumor size
  • downregulates VEGF, improves IFN and IL-2 levels leading to apoptosis
The composition of essential oil of Iranian/Brazilian black cumin seed:
  • α-Thujene 9.8/2.4
  • α-Pinene 3.1/1.2
  • Sabinene 2.2/1.4
  • β-Pinene 3.4/1.3
  • para-Cymene 37.3/-
  • γ-Terpinene 2.0/-
  • Linalool 9.9/-
  • 4-Terpineol 1.0/-
  • alpha-Terpineol 2.2/-
  • Thymoquinone 13.7/11.8
  • Carvacrol 1.6/3.7
  • alpha-Longipinene 2.1/-
  • Longifolene 6.4/5.7
  • Nerol -/1.3
  • Estragole -/1.9
  • Carvone -/2.0
  • Anisaldehyde -/1.7
  • Trans-Anethole -/27.1
  • p-Cymene -/9.0
  • Limonene -/4.3
  • Uvidine -/1.3
  • 2(1H)-Naphthalenone -/2.6
  • Myristicin -/1.4
  • Fenchone -/0.1
  • Apiole -/1.0
[71,74,75,76,77,78,79,80,81,147,148]
4.Houttuynia cordata Thunb. (H. cordata; Saururaceae)May reduce side effects of bleomycine in cancer treatment as:
  • upregulates the level of IFN-γ
  • inhibits β1 (TGF-β1)/Smad signaling pathway in mice
The composition of essential oil isolated from dried aerial part of leafs/fresh whole grass of the plant grown in China:
  • 1-Nonanol 3.10/0.49
  • Decanal 2.68/2.61
  • 2-Undecanone 44.92/48.49
  • Tetradecanal 1.48/0.82
  • β-Pinene 9.95/8.67
  • β-Myrcene 17.68/18.36
  • (E)-3,7-Dimethyl-2,6-octadien-1-ol 1.55/2.44
  • Bornyl acetate 1.89/1.28
  • Geranyl acetate 2.65/0.75
  • Phytol 1.06/0.19
  • Nonterpene compounds 58.34/57.66
  • Aliphatic compounds 58.04/57.50
  • Terpenoids 41.66/42.34
  • Terpene hydrocarbons 31.95/35.79
  • Monoterpene hydrocarbons 30.74/35.27
  • Oxygenated terpenes 9.72/6.55
  • 4-Tridecanone 0.55/1.78
  • α-Pinene 0.63/2.18
  • (1S)-(-)-β-Pinene 0.77/1.64
  • Limonene 0.37/1.35
  • β-Phellandrene 0.53/1.82
[92,93,94,149]
5.Thymus vulgaris L.
(T. vulgaris)
It is involved in antiinflammatory processes by:
  • suppressing transcription factors of the induction of cytokine expression in T cells, the AP-1 and nuclear factors of activated T cells (NFAT)
  • reducing secretion of TNF-, IL-1β, CRP, IL-8 and increasing IL-10 production
  • affecting activity of elastase produced by activated neutrophils and inhibiting COX
  • inhibiting NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways
  • affecting TNF and IL-1β secretion and production of IL-2 and IFN-γ, involved in T cell activation
  • affecting synthesis of LPS-mediated nitric oxide
The composition of essential oil isolated from aerial parts of the plant grown in Nyons, France/Jablanicki, Serbia/Pomoravje District, Serbia/Richerenches, France:
  • α-Pinene 0.47/0.21/1.75/1.32
  • Camphene 1.17/0.38/0.2/1.19
  • Sabinene -/0.05/2.03
  • Myrcene 0.09/0.44/4.0/1.59
  • α-Terpinene -/-/2.65/1.30
  • p-Cymene 0.09/0.18/1.0/20.07
  • Limonene 0.05/0.39/2.8/0.39
  • γ-Terpinene -/0.09/4.58/9.03
  • cis-Sabinene hydrate -/0.31/30.77/0.17
  • Linalool 76.15/7.15/7.89/5.00
  • Camphor 1.79/0.11/0.1/1.42
  • Borneol 0.40/1.00/0.28/1.50
  • Terpinen-4-ol 0.06/0.17/9.5/1.25
  • α-Terpineol 0.11/0.09/2.69/0.16
  • 7-Methylenebicyclo[3.3.1]nonan-3-ol -/-/6.07/-
  • Linalyl acetate 14.26/-/3.40/-
  • Geraniol -/59.75/0.24/0.05
  • Geranial -/1.25/-/-
  • Thymol -/0.42/-/47.06
  • Carvacrol 0.05/-/-/3.24
  • cis-p-Menthadienyl acetate -/0.19/4.75/-
  • Geranyl acetate 0.06/16.72/0.48/-
  • β-Caryophyllene 2.27/3.67/2.03/1.79
  • Geranyl propanoate -/1.26/-/-
[8,97,98,99,100,101,150]
6.Artemisia judaica L.
(A. judaica;
Asteraceae;
Compositae)
It exhibits antiinflamamtory activity by:
  • reducing the TNF and promotes TGF-β1,IL-6, IL-8, leukotriene B4 (LTB4), PGE 2, and IL-1
  • downregulating 5-lipoxygenase (LOX) and COX
The composition of essential oil isolated from leafs of the plant grown in Saudi Arabia/Algeria/Egypt/Sinai, Egypt/Jordan/Libya:
  • Piperitone -/66.17/49.1/29.9/3–15/30.2
  • Camphor -/-/34.5/31.4/0.3–16/-
  • cis-Thujone 2.5/-/-/-/-/-
  • thymol 3.5/-/-/-/-/-
  • trans-sabinyl acetate 3.3/-/-/-/-/-
  • carvacrol 3.5/-/-/-/-/-
  • b-eudesmol 13.1 /-/-/-/-/-
  • eudesma-4 (15), 7-dien-1-b-ol 3.5/-/-/-/-/-
  • hexadecanoic acid 5.7/-/-/-/-/-
  • ethyl cinnamate isomer -/6.11/-/-/11/3.8
  • spathulenol -/2.34/-/-/-/-
  • E-longipinane -/2.55/-/-/-/-
  • Borneol -/-/3.90/5.72/-/-
  • Artemisia ketone -/-/-/-/9–24/-
  • chrysanthenone -/-/-/-/4–31/-
  • cis-Chrysanthenol -/-/-/-/-/9.1
[9,10,107,108,109,110]
7.Patchouli
(Pogostemon cablin,
P. cablin)
Plays a role in antiinflammatory procesess and wound healing by:
  • differentiating between M1 and M2 macrophage phenotypes
  • changing the inflammatory milieu of ApcMin/+ mice, inhibit CD4+CD25+, while stimulating CD4+ and CD8+ cells in the spleen, blood, mesenteric lymph nodes (MLNs), and Peyer’s patches (PPs) of treated mice
The composition of essential oil isolated from leafs of the plant grown in Aceh Indinesia/India:
  • Cis-alpha-Guaiene 1,44/14.6
  • Methanoazule 4,94/-
  • Germacrene 2,3/-1
  • Bicycloheptane 3,87/-
  • Patchouli alcohol 42.75/23.2
  • Delta-Guaiene 28.30/-
  • Azulene 20.48/-
  • Trans Caryophellene 11.84/-
  • Seychellene 10.77/5.6
  • Nephtalene 8.02/-
  • Cycloheptane 6.02/-
  • Alpha Patchoulene 3,53/3.3
  • Caryophyllene 5.73/4.5
  • a-pinene -/0.2
  • b-pinene -/0.4
  • isoledene -/2.6
  • a-copaene -/1.7
  • b-patchoulene -/4.2
  • a-humulene -/0.7
  • selinene -/3.9
[111,151]
8. Echinacea purpurea
(E. purpurea)
L. Moench (Asteraceae)
  • It supports the immune system by stimulation of monocytes and NK cells
The composition of essential oil isolated from the leaf/root of plant grown in South Africa:

  • α-Pinene 2.8/3.7
  • β-Pinene 1.6/1.2
  • α-Phellandrene 6.9/6.6
  • π-Cymene 3.7/2.9
  • Limonene 2.3/1.7
  • Linalool 1.5/2.7
  • Camphor –/3.4
  • Borneol –/2.1
  • p-Cymen-8-ol –/1.2
  • Naphthalene 7.8/6.4
  • Estragole 2.2/3.3
  • Trans-Carveol 4.8/2.6
  • Cis-Carveol 1.0/1.0
  • Carvone 1.0/3.8
  • Peperitone 1.8/-
  • α-Cubebene 1.4/0.9
  • Caryophyllene 4.5/4.0
  • γ-Muurolene 1.2/-
  • Germacrene D 18.1/20.3
  • Caryophyllene oxide 11.3/12.2
  • Viridiflorol2.9/-
  • Cedrol 7.2/10.5
  • Ledol –/3.1
  • α-Cadinol 9.1/5.9
[113,114,152]
9.Cardamom
(Elettaria cardamomum Maton, Zingiberaceae)
It is involved in antiinflammatory response by:
  • reducing the presence of macrophages, monocytes, T lymphocytes in the colonic mucosa and lamina propia and decreasing secretion of nitric oxide, TNF, and IFN-γ in the intestinal tract
  • suppressing secretion of Th1 cytokines including IFN-γ in murine splenocytes and TNF production by mouse peritoneal macrophages
The composition of essential oil isolated from the grains/fruit of the plant grown in Jordan/Mersin Turkey:
  • 1,8-Cineole 8.82/25.6
  • Linalool 6.99/6.4
  • Terpinen-4-ol 1.83/2.8
  • Dihydrocarveol 6.06/
  • Geraniol 4.46/1.6
  • δ-Terpinyl acetate 55.99/40.7
  • Eugenol 2.31/
  • Z-Caryophyllene 3.82/
  • E-Nerolidol 3.07/-
  • α-Pinene -/1.4
  • Sabinene -/2.1
  • Myrecene -/1.4
  • Limonene 1.1/-
  • Linalyl acetate -/2.0
[125,153]
10.Citrus sudachi
(sudachi oil,
Rutaceae)
  • suppresses properties of anti-gen-presentation-related molecules on dendritic cells in vitro
  • suppresses antigen-specific T cell induction in vivo in mice immunized with OVA [127].
  • suppresses antigen-induced lymphocyte activation
The composition of essential oil from fruit of the plant grown in Kagoshima, Japan/Yamaguchi, Japan:
  • α-Pinene 1.78/1.18
  • β-Myrcene 2.97/3.54
  • Limonene 60.30/71.34
  • β-Phellandrene 8.22/7.27
  • α-Terpinene 5.12/5.51
  • p-Cymene 6.08/3.56
  • γ-Elemene 1.93/-
  • α-terpineol -/1.90
  • (E,E)-α-farnesene -/1.00
[127,154,155]
11.Euodia ruticarpa
(E. ruticarpia)
(Rutaceae)
It exhibits anticancer propeties by:
  • increasing the level of IL-1β, TNF-α, IL-6 and IL-10 secreted by macrophages
  • affecting regulation of Th1 (IL-2) and Th2 (IL-10) cytokines production by splenocytes
  • activating NK cells and B cells
The composition of essential oil from leaf /fruit:
  • β-myrcene 31.03/38.14
  • β-phellandrene 18.38/25.89
  • trans-β-ocimene 3.35/-
  • β-ocimene 3.21/17.82
  • (E)-4,8-dimethyl-1,3,7-nonatriene 6.17/-
  • caryophyllene 2.21/-
  • E-nerolidol 21.79/-
  • γ-eudesmol 1.09/-
  • β-eudesmol 1.52/-
  • α-eudesmol 2.1/-
  • α-pinene -/1.63
  • trans-β-ocimene -/12.29
[32,130,131,132,133,134,135,156]
12.Eucalyptus plant (Myrtaceae)
  • Its topical application inhibits edema and enhances vascular permeability in IgE-mediated allergic dermatitis
  • it may stimulate the immune function of the respiratory tract, improves phagocytic activity of macrophages and it can be used as an adjuvant in some infections and inflammatory diseases.
  • It increases podosome density and augments colocalization at the podosomes of the actin core with the ring component vinculin and—takes part in macrophage motility and chemotaxis processes
The composition of essential oil from leaf of the plant Eucalyptus maculate/Eucalyptus globulus
grown in Tanzania:
  • α-Pinene 8.46/23.62
  • β-Myrcene 7.78/8.74
  • p-Cymene 10.10/10.00
  • Eucalyptol 54.29/51.62
  • γ-Terpinene 1.73/2.59
  • Terpinen-4-ol 0.04/2.74
[2,40,137,138,141,142,157]
Table 2. Influence of the most common essential oil constituents on the immune system (activity) and their chemical classification.
Table 2. Influence of the most common essential oil constituents on the immune system (activity) and their chemical classification.
Lp.ConstituentActivityChemical ClassificationLiterature
1α-pinene
  • has no effect on human neutrophil Ca2+ influx
  • is a very low inhibitor of neutrophil chemotaxis
  • inhibits LPS-induced nitrite oxide secretion via reduction of inducible NOs mRNA and protein expressions in macrophages of rats
  • reduces NOs mRNA and protein expressions in RAW 264.7 macrophages
  • inhibits activation of IKK-β, NF-B in human mast cells
  • blocks NF-κB and JNK activation in chondrocytes
  • diminishes the production of IL-6, TNF-α, PGE2, NO production in LPS-stimulated peritoneal macrophages in mice
  • diminishes COX-2 expression in LPS-stimulated peritoneal macrophages in mouse
  • diminishes LPS-induced phosphorylation of MAPKs ERK and JNK in LPS-stimulated peritoneal macrophages in mouse
  • affects IKK expression, p-IB level, NF-B translocation in LPS-stimulated peritoneal macrophages in mouse
Monoterpene hydrocarbons[158,159,160,161,162,163]
2p-cymen-8-ol
  • has no effect on human neutrophil Ca2+ influx
  • does not affect neutrophil chemotaxis
Monoterpene alcohol[158,160]
3limonene,
  • has no effect on human neutrophil Ca2+ influx
  • diminishes chemotaxis of neutrophils and leukocytes when combined with p38 mitogen-activated protein kinases (MAPK) inhibitor
  • reduces leukocytes infiltration
  • reduces levels of TNF-α, IL-1β, IL-6 in in LPS-stimulated RAW 264.7 macrophages
  • reduces the expression of inducible NOs, COX-2 and production of PGE2 in LPS-stimulated RAW 264.7 macrophages
  • reduces the activity of NF-κB in the rat kidney model
  • inhibits mast cells activation and degranulation in the skin
Cyclic
monoterpene
[158,164,165,166,167]
4β-pinene
  • has no effect on human neutrophil Ca2+ influx, but (1S)-(−)-β-pinene stimulated neutrophil Ca2+ influx
  • inhibits neutrophil migration
  • inhibits the formation of 5-LOX (lipoxygenase) in 5-LOX assay
Monoterpene hydrocarbons[158,168]
5camphor
  • has no effect on human neutrophil Ca2+ influx
  • inhibits production of IL-1β, IL-4, TNF-α in gingival tissues
  • inhibits chemotaxis and leukocyte infiltration by diminishing the activity of myeloperoxidase enzyme (MPO)
  • inhibits phorbol-12-myristate-13-acetate/ionomycin (PMA/I)-induced secretion of IL-6 and IL-8 by human gingival fibroblasts
Monoterpenoid[110,169,170]
6myrcene
  • has no effect on human neutrophil Ca2+ influx
  • inhibits NO production in macrophages stimulated by LPS
  • downregulates the production of NO induced by IL-1β in kidney tissues from ADX rats (after andrenalectomy)
  • reduces NF-κB and inducible NOs expression induced by IL-1β in kidney tissues from ADX rats (after andrenalectomy)
  • downregulates IL-6, IL-1β, IL-4, TNF-α COX-2 in kidney tissues from ADX rats (after andrenalectomy)
  • increases the level of IFN-γ in kidney tissues from ADX rats (after andrenalectomy)
  • upregulates IL-10 in kidney tissues from ADX rats (after andrenalectomy)
Monoterpene hydrocarbons[158,165,171]
7β- and α-phellandrene
  • do not inhibit human neutrophil chemotaxis
  • reduce the total human leukocyte influx
  • block NF-kB activity from LPS-stimulated macrophages
  • inhibit neutrophil infiltration and mast cell degranulation
  • reduce production of TNF-α, IL-6, COX-2, IL-1β by LPS-stimulated macrophages
  • decrease the leukocyte migration via:
blocking of TNF-α and IL-6 by resident cells
changing expression of adhesion molecules in endothelial and polymorphonuclear cells
  • inhibit inducible NOs, COX-2 gene transcription as well as IL-1 production by LPS-stimulated macrophages
Monoterpene hydrocarbons[167,172,173,174,175,176]
8spathulenol
  • inhibits neutrophil chemotaxis
  • downregulates lymphocyte activation in a dose-dependent manner
  • blocks IL-1β and IL-6 production by human lymphocyte
  • inhibits human neutrophil function by affecting the activity of:
MAPKAPK2 (MAP kinase-activated protein kinase 2)
JNK3 (mitogen-activated protein kinase 10)
Integrin α-L
BMP2 (bone morphogenetic protein 2)
Oxygenated sesquiterpene [172,177,178,179,180,181]
9myristicin
  • inhibits human neutrophil [Ca2+] influx
  • is hardly able to inhibit neutrophil migration
Phenylpropene[158]
10myrtenol
  • reduces human neutrophil migration
  • reduces myeloperoxidase (MPO) activity in peritoneal fluid collected after carrageenan-induced peritonitis in the mice model
  • reduces IL-1β production in peritonitis in the mice peritonitis model
Monoterpene alcohol[158,182]
11(+/−)-sabinene
  • stimulates human neutrophil Ca2+ influx
  • blocks neutrophil migration
  • blocks inducible NOs expression, in LPS-induced Raw 264.7 macrophages
Monoterpene hydrocarbons[158,183,184]
12γ-terpinene
  • stimulates human neutrophil Ca2+ influx
  • blocks neutrophil migration
  • inhibits expression of inducible NOs mRNA in LPS-induced Raw 264.7 macrophages
Monoterpene hydrocarbons[158,163]
13terpinen-4-ol
  • has no effect on human neutrophil Ca2+ influx
  • inhibits production of TNFα, IL-1β, IL-6, IL-8, IL-10, PGE2 by human LPS- stimulated monocytes
  • diminishes IL-1β, IL-6 and IL-10 production by human TLR4 and TLR2/TLR4-activated macrophages
Oxygenated monoterpene[185,186,187]
14terpinolene
  • has no effect on human neutrophil and FPR1-HL60 cells Ca2+ influx
  • improves proliferation and migration of L929 fibroblast cells
  • inhibits NO production by LPS-stimulated RAW 264.7 cells
  • its pre-incubation with RAW 264.7 macrophage cells leads to suppression of superoxide anion generation in LPS-stimulated macrophages
  • diminishes IL-6 and TNF-α secretion in LPS-stimulated RAW 264.7 macrophage cells
  • inhibits NF-κB activation in human embryonic kidney (HEK) 293 cells
Monoterpene hydrocarbons[158,160,188]
15p-cymene
  • has no effect on human neutrophil Ca2+ influx
  • blocks NO secretion via reduction of inducible NOs mRNA and protein expressions in RAW 264.7 cells
  • inhibits IL-6 production in the mouse model of colitis
  • forms 5-LOX (lipoxygenase) in 5-LOX assay
Monoterpene[98,163,168,185,189]
16nerolidol
  • inhibits agonist-induced activation of human neutrophils
  • reduces CXCL1, IL-8, CCL2, mRNA expression in HT-29 cells
  • reduces IL-6, IL-1β, TNF-α production by dextran sodium sulfate (DSS)-treated C57Bl6 mice
  • reduces COX-2, inducible NOs proteins expression in the rat model of neuro-inflammation
  • diminishes the influx of polymorphonuclear cells in carrageenan-induced peritonitis in mice
Oxygenated sesquiterpenes[185,190,191]
17myrtenol
  • has no effect on human neutrophil Ca2+ influx
  • inhibits chemotaxis of human neutrophils
  • reduces TNF-α, IL-1β, IL-6 levels in the peritoneal exudate of mice with carrageenan-induced peritonitis
Monoterpene alcohol[158,182,192]
18(±)-bornyl acetate
  • activates human neutrophils (via Ca2+ influx)
  • inhibits human neutrophil migrations
  • reduces IL-11 mRNA and protein expression in human chondrocytes
  • acts antagonistically on IL-1β upregulation of matrix metalloproteinase (MMP) MMP-1 and MMP-13 in human chondrocytes
  • diminishes the number of LPS-stimulated neutrophils and macrophages in murine bronchoalveolar lavage fluid
  • blocks expression of IL-1β, TNF in human umbilical vein endothelial cells (HUVECs) and RAW 264.7 macrophages
  • reduces LPS-induced activation of MAPK and NF-κB in acute lung injury and acute respiratory distress syndrome (ALI) model in mice
  • diminishes LPS-induced secretion of TNF-α, IL-1β and IL-6 in the mouse model of acute lung injury and acute respiratory distress syndrome (ALI)
Bicyclic monoterpene[185,193,194,195,196]
19borneol
  • inhibits fMLF- and WKYMVM-stimulated neutrophils
  • inhibits phorbol-12-myristate-13-acetate/ionomycin (PMA/I)-induced secretion of IL-6 and IL-8 by human gingival fibroblasts
  • inhibits TNF-α, IL-1β, IL-6 and IL-8 secretion by LPS-stimulated monocytes
  • block production of NF-ĸB, COX-2, LOX-5 in human rheumatoid disease
Oxygenated monoterpenes[110,185,197,198].
20geraniol
  • leads to prostate cancer cells autophagy via blocking Akt signaling and activation of AMPK signaling
  • diminishes IL-6 and TNFα productions by BV-2 cells
Monoterpenoid[169,199,200]
21o-cymene
  • diminishes carrageenan induced TNF-α secretion in the mouse model of pleurisy
  • affects carrageenan-induced migration of leukocytes, neutrophils in the mouse model of pleurisy
  • reduces production of TNF-α, IL-1β and IL-6 in the mouse model of LPS-induced acute lung injury
  • reduces the number of neutrophils and macrophages in the mouse model of LPS-induced acute lung injury
  • reduces phosphorylation of JNK, ERK1/2, p38 MAPK in the mouse model of LPS-induced acute lung injury
  • inhibits NF-κB kinases in the mouse model of LPS-induced acute lung injury
Monoterpene[201,202]
221.8-cineole
  • reduces IL-4, IL-5, IL-10 production in nasal lavage fluids and the levels of IL-1β, IL-6, TNF-α and IFN-γ in lung tissues in influenza viral infection in mice
  • improves IκBα proteins level, which leads to inhibition of the nuclear import of NFκB in the human cancer cell lines U373 and HeLa
  • inhibits the NOD-like receptor pyrin domain-containing 3 (NLRP3) activity—regulator of IL-1β secretion and caspase-1 activity as well as diminishes NF-κB and p38 activity in murine alveolar macrophages
  • affects M2 macrophages polarization by binding to peroxisome proliferator-activated receptor-γ (PPARγ) in the mice model of dextran sodium sulfate (DSS)-induced colitis
  • has no effect on human neutrophil Ca2+ influx
  • diminishes leukotriene B4 and prostaglandin E2 production by monocytes in the human model of asthma
  • inhibits phorbol-12-myristate-13-acetate/ionomycin (PMA/I)- induced secretion of IL-6 and IL-8 by human gingival fibroblasts
  • inhibits TNF-α, IL-1β, IL-6 and IL-8 secretion by LPS-stimulated monocytes
Monoterpene[110,126,160,161,198,202,203,204,205,206,207]
23linalool
  • promotes IF-γ, IL−13, IL-2, IL-21, IL-21R, IL-4, IL-6sR, TNF-α secretion in T-47D cells
  • promotes CD40, IFN-γ, IL-12 p40, IL-13, IL-17F, IL-1β, IL-2, IL-21, IL-21R, IL-23p19, IL-4, IL-6sR and TNF-α production by human lymphocyte
  • inhibits IL-6 and TNFα secretion by BV-2 cells
  • has no effect on human neutrophil Ca2+ influx
Cyclic
monoterpene
[185,201,208]
24Cis thujanol
  • reduces expressions of IL-6 and TNFα mRNA in BV-2 cells
  • promotes IL-6 production in BV-2 cells
  • slightly reduces TNFα secretion in BV-2 cells
  • inhibits phorbol-12-myristate-13-acetate/ionomycin (PMA/I)-induced secretion of IL-6 and IL-8 by human gingival fibroblasts
Monoterpenoid[10,163,200]
25b-caryophyllene
  • reduces neutrophils chemotaxis
  • blocks IL1-β,TNF-α and IL-6 formation in murine macrophage J774A.1 cells
Sesquiterpene hydrocarbons[168,177]
26citronellal
  • decreases iNOS mRNA and COX-2 transcription in LPS-induced RAW 264.7 cells
  • diminishes NO, PGE2 production in murine macrophage
  • blocks carrageenan-induced neutrophil migration in rat carrageenin-induced pleurisy
Monoterpene[167,209,210]
27Alpha terpineol
  • reduces neutrophils migration
  • inhibits IL-6 formation in epithelial buccal cells
  • reduces production of IL-1β, Il-6 and TNF-α by LPS-induced human macrophages
  • inhibits LPS-induced activation of NF-kB and ERK pathways but stimulates activation of p38 MAPK in human macrophages
  • inhibits expression of IL-1β, IL-6, TNF-α, COX-2, inducible NOs in the mice model of bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC)
  • inhibits NF-κB activation in LPS-stimulated mice peritoneal macrophages
  • downregulates the expressions of COX-2 and inducible NOs in LPS-stimulated mice peritoneal macrophages
Oxygenated monoterpenes[174,176,187,197,211,212,213]
28carvacrol
  • reduces IL-1β, PGE2 production and COX-2, IL-1β mRNA expression in the paw edema model
  • enhances IL-10 mRNA expression in the paw edema model
Monoterpene[214]
29Thymoquinone
  • diminishes IL-1β, IL-6, TNF-α, IFN-γ and PGE2 production but increases IL-10 level in the rat model of arthritis
  • diminishes inducible NOs mRNA and protein expressions in the rat model of arthritis and in RAW 264.7 macrophages
  • inhibits COX2 expression and prostaglandins synthesis in mice with allergic airway inflammation
  • inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated COX-2 expression as well as NF-κB activation in the nude mouse skin model
  • its supplementation in streptozotocin (STZ)-stimulated diabetic blocks COX-2 expression in pancreatic tissue in the rat model of diabetes
  • when injected intraperitoneally, reduces the number of blood leukocytes and plasma IL-6 level in the murine model
  • reduces IgE level in serum in the rodent model of airway allergic inflammation
  • reduces TNF-α mRNA levels in the lungs in the rodent model of airway allergic inflammation
  • reduces TGF-β1 mRNA and inducible NOs gene transcripts level in the rodent model of airway allergic inflammation
Monoterpene[164,215,216,217,218,219,220,221,222]
Abbreviations: COX—Cyclooxygenase; IL—Interleukin; inducible NOs—Inducible Nitric Oxide Synthase; LOX—Lipoxygenase; LPS—Lipopolysaccharide; NF-kB—Nuclear Factor kappa β; NO—Nitric Oxide; PGE2—Prostaglandin E2; PLA2—Phospholipase A2; MAPKs—mitogen-activated protein kinases; ERK—extracellular signal-regulated kinases; IKK-β—IκB kinase subunit–β; NF-β—Nuclear Factor kappa β; MPO—myeloperoxidase enzyme; (PMA/I)—phorbol-12-myristate-13-acetate/ionomycin; MAPKAPK2—MAP kinase-activated protein kinase 2; JNK—c-Jun N-terminal kinase; BMP2—bone morphogenetic protein 2; DSS—dextran sodium sulfate; TLR—Toll-like receptor; MMP—metalloproteinase; ALI—acute respiratory distress syndrome; Akt—Protein kinase B; IκBα—inhibitors of NF-κB; NLRP3—NOD-like receptor pyrin domain-containing 3; PPARγ—peroxisome proliferator-activated receptor-γ; DSS—dextran sodium sulfate; TPA—12-O-tetradecanoylphorbol-13-acetate; STZ—streptozotocin; TGF-β1—Transforming growth factor B; BV—bacterial vaginosis; VVC—vulvovaginal candidiasis.be presented in Table 2.

5. Conclusions

Traditional medicine has used various plants to treat health problems for centuries. This review describes selected essential oils exhibiting immunostimulating properties. Although new synthetic drugs have been invented, methods supporting their treatment are still being sought, especially in the treatment of infectious diseases. The ubiquitous growing drug resistance of etiological factors of infections is becoming a serious therapeutic problem both in inpatient (hospital infections) and outpatient treatment. This problem can be solved by the application of essential oils, which possess many bioactive properties. Supporting the immune system is particularly important in the treatment of infectious diseases of various etiologies. This is of great importance, especially to avoid recurrences, and is also necessary in the treatment of chronic infectious problems such as skin and subcutaneous tissue infections, including difficult-to-heal wounds and ulcers. The active compounds of many essential oils, by modulating the immune response, have an inhibitory effect on the inflammatory process. It is known that components of essential oils generate a specific synergistic effect that cannot be generated by synthetic drugs. It is also possible that components of oils positively interact with recommended anti-inflammatory and antimicrobial drugs. Thus, there is a need to explore possible synergies in future research to implement essential oils and their active ingredients in medical practice.

Author Contributions

Conceptualization, M.G., M.S. and P.K.; formal analysis, M.G., M.S., A.K. and P.K.; writing—original draft preparation, M.G., M.S. and P.K.; writing—review and editing, M.G., M.S., K.H. and P.K.; visualization, P.K.; supervision, A.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would also like to thank Dorota Wawrzyniak, from the Foreign Language Centre of the Medical University of Lodz, Poland, for a language consultation.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ataur-Rahman, F.R.S.; Iqbal Choudhary, M. (Eds.) Medicinal plants as immune response enhancers to prevent infectious diseases of veterinary interest. In Frontiers in Anti-Infective Drug Discovery; Bentham Science Publishers: Sharja, United Arab Emirates, 2017; Volume 5, pp. 132–144. [Google Scholar]
  2. Zonfrillo, M.; Andreola, F.; Krasnowska, E.K.; Sferrazza, G.; Pierimarchi, P.; Serafino, A. Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages. Molecules 2022, 27, 3488. [Google Scholar] [CrossRef]
  3. Medzhitov, R.; Janeway, C., Jr. Innate immunity. N. Engl. J. Med. 2000, 343, 338. [Google Scholar] [CrossRef]
  4. Sampson, A.P. The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy 2000, 30, 22–27. [Google Scholar] [CrossRef] [PubMed]
  5. Kaisho, T.; Akira, S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 2006, 117, 979. [Google Scholar] [CrossRef] [PubMed]
  6. Carter, C.M. Alterations in blood components. Compr. Toxicol. 2018, 2018, 249–293. [Google Scholar] [CrossRef]
  7. Naseem, S.; Iqbal, R.; Munir, T. Role of interleukin-6 in immunity: A Review. Int. J. Life Sci. Res. 2016, 4, 268–274. [Google Scholar]
  8. Ismail, H.T.H. The ameliorative efficacy of Thymus vulgaris essential oil against Escherichia coli O157:H7-induced hematological alterations, hepatorenal dysfunction and immune-inflammatory disturbances in experimentally infected rats. Environ. Sci. Pollut. Res. 2022, 29, 41476–41491. [Google Scholar] [CrossRef] [PubMed]
  9. Pereira Beserra, F.; Sérgio Gushiken, L.F.; Vieira, A.J.; Augusto Bérgamo, D.; Luísa Bérgamo, P.; Oliveira de Souza, M.; Alberto Hussni, C.; Kiomi Takahira, R.; Henrique Nóbrega, R.; Monteiro Martinez, E.R. From Inflammation to Cutaneous Repair: Topical Application of Lupeol Improves Skin Wound Healing in Rats by Modulating the Cytokine Levels, NF-κB, Ki-67, Growth Factor Expression, and Distribution of Collagen Fibers. Int. J. Mol. Sci. 2020, 21, 4952. [Google Scholar] [CrossRef] [PubMed]
  10. Mohammed, H.A.; Qureshi, K.A.; Ali, H.M.; Al-Omar, M.S.; Khan, O.; Mohammed, S.A. Bio-Evaluation of the Wound Healing Activity of Artemisia judaica L. as Part of the Plant’s Use in Traditional Medicine; Phytochemical, Antioxidant, Anti-Inflammatory, and Antibiofilm Properties of the Plant’s Essential Oils. Antioxidants 2022, 11, 332. [Google Scholar] [CrossRef]
  11. Guermonprez, P.; Amigorena, S. Pathways for antigen cross presentation. Springer Semin. Immunopathol. 2005, 26, 257–271. [Google Scholar] [CrossRef]
  12. Kaisho, T.; Akira, S. Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med. 2003, 3, 373. [Google Scholar] [CrossRef] [PubMed]
  13. Badea, D.; Genunche-Dumitrescu, A.; Badea, M.; Marinaș, C.; Cojan, T.T. Immunoglobulins: Functions, biosynthesis and biological properties. Res. Sci. Today J. 2020, 8, 67–74. [Google Scholar] [CrossRef]
  14. Mauri, C.; Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 2012, 30, 221. [Google Scholar] [CrossRef] [PubMed]
  15. Parkin, J.; Cohen, B. An overview of the immune system. Lancet 2001, 357, 1777. [Google Scholar] [CrossRef]
  16. Maschalidi, S.; Mehrotra, P.; Keçeli, B.N.; De Cleene, H.K.L.; Lecomte, K.; Van der Cruyssen, R.; Janssen, P.; Pinney, J.; van Loo, G.; Elewaut, D.; et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. Nature 2022, 606, 776–784. [Google Scholar] [CrossRef]
  17. Moulik, P.K.; Mtonga, R.; Gill, G.V. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003, 26, 491–494. [Google Scholar] [CrossRef]
  18. Sayama, K.; Komatsuzawa, H.; Yamasaki, K.; Shirakata, Y.; Hanakawa, Y.; Ouhara, K.; Tokumaru, S.; Dai, X.; Tohyama, M.; Ten Dijke, P.; et al. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur. J. Immunol. 2005, 35, 1886. [Google Scholar] [CrossRef]
  19. Sorensen, O.E.; Cowland, J.B.; Theilgaard-Monch, K.; Liu, L.; Ganz, T.; Borregaard, N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 2003, 170, 5583. [Google Scholar] [CrossRef]
  20. Steinstraesser, L.; Koehler, T.; Jacobsen, F.; Daigeler, A.; Goertz, O.; Langer, S.; Kesting, M.; Steinau, H.; Eriksson, E.; Hirsch, T. Host defense peptides in wound healing. Mol. Med. 2008, 14, 528. [Google Scholar] [CrossRef]
  21. Chen, L.; Guo, S.; Ranzer, M.J.; Dipietro, L.A. Toll-like receptor 4 has an essential role in early skin wound healing. J. Investig. Dermatol. 2013, 133, 258. [Google Scholar] [CrossRef]
  22. Kluwe, J.; Mencin, A.; Schwabe, R.F. Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. 2009, 87, 125. [Google Scholar] [CrossRef] [PubMed]
  23. Gillitzer, R.; Goebeler, M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 2001, 69, 513. [Google Scholar] [CrossRef] [PubMed]
  24. Strbo, N.; Yin, N.; Stojadinovic, O. Innate and Adaptive Immune Responses in Wound Epithelialization. Adv. Wound Care 2014, 3, 492–501. [Google Scholar] [CrossRef] [PubMed]
  25. Castanheira, F.V.; Kubes, P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood 2019, 133, 2178–2185. [Google Scholar] [CrossRef]
  26. Gurjala, A.N.; Geringer, M.R.; Seth, A.K.; Hong, S.J.; Smeltzer, M.S.; Galiano, R.D.; Leung, K.P.; Mustoe, T.A. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair. Regen. 2011, 19, 400–410. [Google Scholar] [CrossRef]
  27. Moser, C.; Pedersen, H.T.; Lerche, C.J.; Kolpen, M.; Line, L.; Thomsen, K.; Høiby, N.; Jensen, P. Biofilms and host response: Helpful or harmful. APMIS 2017, 125, 320–338. [Google Scholar] [CrossRef]
  28. Hurlow, J.; Bowler, P.G. Acute and chronic wound infections: Microbiological, immunological, clinical and therapeutic distinctions. J. Wound Care 2022, 31, 436–445. [Google Scholar] [CrossRef]
  29. World Health Organization. WHO Global Report on Traditional and Complementary Medicine; World Health Organization: Genèva, Switzerland, 2019. [Google Scholar]
  30. Anand, U.; Jacobo-Herrera, N.J.; Altemimi, A.B.; Lakhssassi, N. A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery. Metabolites 2019, 9, 258. [Google Scholar] [CrossRef]
  31. Sarto, M.P.M.; da Silva, H.F.L.; de Souza Fernandes, N.; de Abreu, A.P.; Junior, G.Z.; de Ornelas Toledo, M.J. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi, I.I. BMC Complement. Med. Ther. 2021, 21, 77. [Google Scholar] [CrossRef]
  32. Yeh, T.-H.; Lin, J.-Y. Active Ingredients from Euodia ruticarpa Steam Distilled Essential Oil Inhibit PC-3 Prostate Cancer Cell Growth via Direct Action and Indirect Immune Cells Conditioned Media In Vitro. Curr. Issues Mol. Biol. 2021, 43, 996–1018. [Google Scholar] [CrossRef]
  33. Shiina, Y.; Funabashi, N.; Lee, K.; Toyoda, T.; Sekine, T.; Honjo, S.; Hasegawa, R.; Kawata, T.; Wakatsuki, Y.; Hayashi, S. Relaxation effects of lavender aromatherapy improve coronary flow velocity reserve in healthy men evaluated by transthoracic doppler echocardiography. Int. J. Cardiol. Res. 2008, 129, 193–197. [Google Scholar] [CrossRef] [PubMed]
  34. Li, M.; Wang, C. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: A review. J. Ethnopharmacol. 2020, 263, 113231. [Google Scholar] [CrossRef] [PubMed]
  35. Orhan, I.E.; Mesaik, M.A.; Jabeen, A.; Kan, Y. Immunomodulatory properties of various natural compounds and essential oils through modulation of human cellular immune response. Ind. Crop Prod. 2016, 81, 117–122. [Google Scholar] [CrossRef]
  36. Chandan, G.; Kumar, C.; Verma, M.K.; Satti, N.K.; Saini, A.K.; Saini, R.V. Datura stramonium essential oil composition and it’s immunostimulatory potential against colon cancer cells. 3 Biotech 2020, 10, 451. [Google Scholar] [CrossRef]
  37. Ganesh, K.; Stadler, Z.K.; Cercek, A.; Mendelsohn, R.B.; Shia, J.; Segal, N.H.; Diaz, L.A. Immunotherapy in colorectal cancer: Rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 361–375. [Google Scholar] [CrossRef]
  38. Sandner, G.; Heckmann, M.; Weghuber, J. Immunomodulatory activities of selected essential oils. Biomolecules 2020, 10, 1139. [Google Scholar] [CrossRef] [PubMed]
  39. Tullio, V.; Roana, J.; Cavallo, L.; Mandras, N. Immune Defences: A View from the Side of the Essential Oils. Molecules 2023, 28, 435. [Google Scholar] [CrossRef]
  40. Serafino, A.; Sinibaldi Vallebona, P.; Andreola, F.; Zonfrillo, M.; Mercuri, L.; Federici, M.; Rasi, G.; Garaci, E.; Pierimarchi, P. Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response. BMC Immunol. 2008, 9, 17. [Google Scholar] [CrossRef]
  41. Ciesielska-Figlon, K.; Daca, A.; Kokotkiewicz, A.; Łuczkiewicz, M.; Zabiegała, B.; Witkowski, J.M.; Lisowska, K.A. The influence of Nigella sativa essential oil on proliferation, activation, and apoptosis of human T lymphocytes in vitro. Biomed. Pharmacother. 2022, 153, 113349. [Google Scholar] [CrossRef]
  42. Kutlu, Z.; Gulaboglu, M.; Halıcı, Z.; Cınar, I.; Dıyarbakır, B. Biochemical Research of the Effects of Essential Oil Obtained from the Fruit of Myrtus communis L. on Cell Damage Associated with Lipopolysaccharide-Induced Endotoxemia in a Human Umbilical Cord Vein Endothelial Cells. Biochem. Genet. 2020, 59, 315–334. [Google Scholar] [CrossRef]
  43. Nikoliĉ, M.; Glamoĉlija, J.; Ferreira, I.C.; Calhelha, R.C.; Fernandes, Â.; Markoviĉ, T.; Markoviĉ, D.; Giweli, A.; Sokoviĉ, M. Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L., Thymus algeriensis Boiss. and Reut and Thymus vulgaris L. essential oils. Ind. Crop. Prod. 2014, 52, 183–190. [Google Scholar] [CrossRef]
  44. Samuelson, R.; Lobl, M.; Higgins, S.; Clarey, D.; Wysong, A. The effects of lavender essential oil on wound healing: A review of the current evidence. J. Altern. Complement. Med. 2020, 26, 680–690. [Google Scholar] [CrossRef] [PubMed]
  45. Valdivieso-Ugarte, M.; Gomez-Llorente, C.; Plaza-Díaz, J.; Gil, Á. Antimicrobial, antioxidant, and immunomodulatory properties of essential oils: A systematic review. Nutrients 2019, 11, 2786. [Google Scholar] [CrossRef] [PubMed]
  46. Peterfalvi, A.; Miko, E.; Nagy, T.; Reger, B.; Simon, D.; Miseta, A.; Czéh, B.; Szereday, L. Much More Than a Pleasant Scent: A Review on Essential Oils Supporting the Immune System. Molecules 2019, 11, 4530. [Google Scholar] [CrossRef] [PubMed]
  47. Sisay, M.; Gashaw, T. Ethnobotanical, Ethnopharmacological, and Phytochemical Studies of Myrtus communis Linn: A Popular Herb in Unani System of Medicine. J. Evid. Based Integr. Med. 2017, 22, 1035–1043. [Google Scholar] [CrossRef]
  48. Hennia, A.; Nemmiche, S.; Dandlen, S.; Miguel, M.G. Myrtus communis essential oils: Insecticidal, antioxidant and antimicrobial activities: A review. J. Essent. Oil Res. 2019, 31, 487–545. [Google Scholar] [CrossRef]
  49. Alipour, G.; Dashti, S.; Hosseinzadeh, H. Review of Pharmacological Effects of Myrtus communis L. and its Active Constituents. Phytother. Res. 2014, 28, 1125–1136. [Google Scholar] [CrossRef]
  50. Elfadaly, H.A.; Hassanain, N.A.; Shaapan, R.M.; Hassanain, M.A.; Barakat, A.M.A.; AbdelRahma, K.A. Molecular Detection and Genotyping of Toxoplasma gondii from Egyptian Isolates. Asian, J. Epidemiol. 2016, 10, 37–44. [Google Scholar] [CrossRef]
  51. Oliveira, C.B.S.; Meurer, Y.S.R.; Medeiros, T.L.; Pohlit, A.M.; Silva, M.V.; Mineo, T.W.P.; Andrade-Neto, V.F. Anti-ToxoplasmaActivity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis. J. Parasitol. 2016, 102, 369–376. [Google Scholar] [CrossRef]
  52. Mahmoudvand, H.; Fallahi, S.; Mahmoudvand, H.; Shakibaie, M.; Harandi, M.F.; Dezaki, E.S. Efficacy of Myrtus communis L. to Inactivate the Hydatid Cyst Protoscoleces. J. Investig. Surg. 2015, 29, 137–143. [Google Scholar] [CrossRef]
  53. Ríos, J.L.; Recio, M.C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80–84. [Google Scholar] [CrossRef] [PubMed]
  54. Mahmoudvand, H.; Ezzatkhah, F.; Sharififar, F.; Sharifi, I.; Dezaki, E.S. Antileishmanial and Cytotoxic Effects of Essential Oil and Methanolic Extract of Myrtus communis L. Korean J. Parasitol. 2015, 53, 21–27. [Google Scholar] [CrossRef] [PubMed]
  55. Shaapan, R.M.; Al-Abodi, H.R.; Alanazi, A.D.; Abdel-Shafy, S.; Rashidipour, M.; Shater, A.F.; Mahmoudvand, H. Myrtus communis Essential Oil; Anti-Parasitic Effects and Induction of the Innate Immune System in Mice with Toxoplasma gondii Infection. Molecules 2021, 26, 819. [Google Scholar] [CrossRef] [PubMed]
  56. Delfani, S.; Mohammadrezaei-Khorramabadi, R.; Ghamari, S.; Boroujeni, R.K.; Khodabandeloo, N.; Khorzoughi, M.G.; Shahsavari, S. Systematic review for phytotherapy in Streptococcus Mutans. J. Pharm. Sci. Res. 2017, 9, 552. [Google Scholar]
  57. Mose, J.M.; Kagira, J.M.; Kamau, D.M.; Maina, N.; Ngotho, M.; Karanja, S.M. A Review on the Present Advances on Studies of Toxoplasmosis in Eastern Africa. Biomed. Res. Int. 2020, 2020, 7135268. [Google Scholar] [CrossRef] [PubMed]
  58. Delfani, S.; Mohammadrezaei-Khorramabadi, R.; Abbaszadeh, S.; Naghdi, N.; Shahsavari, S. Phytotherapy for Streptococcus pyogenes. J. Pharm. Sci. Res. 2017, 9, 513. [Google Scholar]
  59. Shin, S.H.; Ye, M.K.; Chae, M.H.; Lee, D.W. Chamaecyparis obtusa Essential Oil Inhibits House Dust Mite Induced Nasal Epithelial Cell Activation and Immune Responses. J. Oleo Sci. 2021, 70, 431–438. [Google Scholar] [CrossRef]
  60. Ramadan, M.F.; Asker, M.M.S.; Tadros, M. Antiradical and antimicrobial properties of cold-pressed black cumin and cumin oils. Eur. Food Res. Technol. 2012, 234, 833–844. [Google Scholar] [CrossRef]
  61. Ahmad, I.; Tripathi, J.; Manik, S.; Umar, L.; Rabia, J. Preliminary Phytochemical Studies of the Miracle Herb of the Century, Nigella sativa L. (Black Seed) Indo Am. J. Pharm. Res. 2013, 3, 3000–3007. [Google Scholar]
  62. Ali, S.A.; Parveen, N.; Ali, A.S. Links between the Prophet Muhammad (PBUH) recommended foods and disease management: A review in the light of modern superfoods. Int. J. Health Sci. 2018, 12, 61–69. [Google Scholar]
  63. Chaudhry, Z.; Khera, R.A.; Hanif, M.A.; Ayub, M.A.; Sumrra, S.H. Chapter 13—Cumin. In Medicinal Plants of South Asia; Hanif, M.A., Nawaz, H., Khan, M.M., Byrne, H.J., Eds.; Elsevier: Amsterdam, The Netherlands, 2020; pp. 165–178. [Google Scholar]
  64. Kooti, W.; Hasanzadeh-Noohi, Z.; Sharafi-Ahvazi, N.; Asadi-Samani, M.; Ashtary-Larky, D. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa) Chin. J. Nat. Med. 2016, 14, 732–745. [Google Scholar] [CrossRef]
  65. Haq, A.; Lobo, P.I.; Al-Tufail, M.; Rama, N.R.; Al-Sedairy, S.T. Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int. J. Immunopharmacol. 1999, 21, 283–295. [Google Scholar] [CrossRef] [PubMed]
  66. Halawani, E. Antibacterial activity of thymo-quinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics. Adv. Biol. Res. 2009, 3, 148–152. [Google Scholar]
  67. Gali-Muhtasib, H.; Ocker, M.; Kuester, D.; Krueger, S.; El-Hajj, Z.; Diestel, A.; Evert, M.; El-Najjar, N.; Peters, B.; Jurjus, A.; et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J. Cell. Mol. Med. 2008, 12, 330–342. [Google Scholar] [CrossRef]
  68. Carroll, J.F.; Babish, J.G.; Pacioretty, L.M.; Kramer, M. Repellency to ticks (Acari: Ixodidae) of extracts of Nigella sativa (Ranunculaceae) and the anti-inflammatory DogsBestFriend™. Exp. Appl. Acarol. 2016, 70, 89–97. [Google Scholar] [CrossRef]
  69. Oskouei, Z.; Akaberi, M.; Hosseinzadeh, H. A glance at black cumin (Nigella sativa) and its active constituent, thymoquinone, in ischemia: A review. Iran. J. Basic Med. Sci. 2018, 21, 1200–1209. [Google Scholar] [CrossRef]
  70. Haseena, S.; Aithal, M.; Das, K.K.; Saheb, S.H. Phytochemical analysis of Nigella sativa and its effect on reproductive system. J. Pharm. Sci. Res. 2015, 7, 514–517. [Google Scholar]
  71. Islam, M.N.; Hossain, K.S.; Sarker, P.P.; Ferdous, J.; Hannan, M.A.; Rahman, M.M.; Chu, D.T.; Uddin, M.J. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytother. Res. 2021, 35, 1329–1344. [Google Scholar] [CrossRef]
  72. Hosseinzadeh, H.; Taiari, S.; Nassiri-Asl, M. Effect of thymoquinone, a constituent of Nigella sativa L., on ischemia-reperfusion in rat skeletal muscle. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2012, 385, 503–508. [Google Scholar] [CrossRef]
  73. Dwita, L.P.; Yati, K.; Gantini, S.N. The anti-inflammatory activity of nigella sativa balm sticks. Sci. Pharm. 2019, 87, 3. [Google Scholar] [CrossRef]
  74. Hossen, M.J.; Yang, W.S.; Kim, D.; Aravinthan, A.; Kim, J.H.; Cho, J.Y. Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Sci. Rep. 2017, 7, 42995. [Google Scholar] [CrossRef] [PubMed]
  75. Ebrahimi, H.; Fallahi, M.; Khamaneh, A.M.; Ebrahimi Saadatlou, M.A.; Saadat, S.; Keyhanmanesh, R. Effect of alpha-Hederin on IL-2 and IL-17 mRNA and miRNA-133a levels in lungs of ovalbumin-sensitized male rats. Drug Dev. Res. 2016, 77, 87–93. [Google Scholar] [CrossRef] [PubMed]
  76. Bordoni, L.; Fedeli, D.; Nasuti, C.; Maggi, F.; Papa, F.; Wabitsch, M.; De Caterina, R.; Gabbianelli, R. Antioxidant and anti-inflammatory properties of nigella sativa oil in human pre-adipocytes. Antioxidants 2019, 8, 51. [Google Scholar] [CrossRef]
  77. Attia, H.N.; Ibrahim, F.M.; Maklad, Y.A.; Ahmed, K.A.; Ramadan, M.F. Characterization of antiradical and anti-inflammatory activities of some cold pressed oils in carrageenan-induced rat model of acute inflammation. Der Pharma. Chem. 2016, 8, 148–158. [Google Scholar]
  78. Hannan, M.A.; Rahman, M.A.; Sohag, A.A.M.; Uddin, M.J.; Dash, R.; Sikder, M.H.; Rahman, M.S.; Timalsina, B.; Munni, Y.A.; Sarker, P.P.; et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021, 13, 1784. [Google Scholar] [CrossRef] [PubMed]
  79. Cobourne-Duval, M.K.; Taka, E.; Mendonca, P.; Soliman, K.F.A. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells. J. Neuroimmunol. 2018, 320, 87–97. [Google Scholar] [CrossRef]
  80. Velagapudi, R.; El-Bakoush, A.; Lepiarz, I.; Ogunrinade, F.; Olajide, O.A. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Mol. Cell. Biochem. 2017, 435, 149–162. [Google Scholar] [CrossRef]
  81. Abulfadl, Y.S.; El-Maraghy, N.N.; Ahmed, A.A.E.; Nofal, S.; Abdel-Mottaleb, Y.; Badary, O.A. Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling. Hum. Exp. Toxicol. 2018, 37, 1092–1104. [Google Scholar] [CrossRef]
  82. Sheik, N.M.M.; Jaikumar, K.; Marimuthu, S.; Wyson, W.J.; Anand, D.; Saravanan, P. In vitro immunostimulation activity of Nigella sativa Linn. and psoralea Corylifolia Linn. seeds using a murine macrophage cell line. Asian J. Pharm. Clin. Res. 2017, 10, 329–332. [Google Scholar]
  83. Hakim, A.S.; Abouelhag, H.A.; Abdou, A.M.; Fouad, E.A.; Khalaf, D.D. Assessment of immunomodulatory effects of black cumin seed (Nigella Sativa) extract on macrophage activity in vitro. Int. J. Vet. Sci. 2019, 8, 385–389. [Google Scholar]
  84. Koshak, A.E.; Yousif, N.M.; Fiebich, B.L.; Koshak, E.A.; Heinrich, M. Comparative immunomodulatory activity of Nigella sativa L. preparations on proinflammatory mediators: A focus on asthma. Front. Pharm. 2018, 9, 1075. [Google Scholar] [CrossRef] [PubMed]
  85. Meles, D.K.; Safitri, E.; Mustofa, I.; Susilowati, S.; Putri, D.K.S.C. Immunomodulatory Activity of Black Jinten Oil (Nigella sativa) as Macrophage Activator for Salmonella typimurium Infected Rat. Indian Vet. J. 2020, 97, 12–14. [Google Scholar]
  86. Kensara, O.A.; El-Shemi, A.G.; Mohamed, A.M.; Refaat, B.; Idris, S.; Ahmad, J. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Drug Des. Dev. Ther. 2016, 10, 2239–2253. [Google Scholar]
  87. Talib, W.H. Regressions of breast carcinoma syngraft following treatment with piperine in combination with thymoquinone. Sci. Pharm. 2017, 85, 27. [Google Scholar] [CrossRef] [PubMed]
  88. Kumar, M.; Prasad, S.K.; Hemalatha, S. A Current Update on the Phytopharmacological Aspects of Houttuynia Cordata Thunb. Pharmacogn. Rev. 2014, 8, 22–35. [Google Scholar] [CrossRef]
  89. Lu, H.; Wu, X.; Liang, Y.; Zhang, J. Variation in Chemical Composition and Antibacterial Activities of Essential Oils from Two Species of Houttuynia THUNB. Chem. Pharm. Bull. 2006, 54, 936–940. [Google Scholar] [CrossRef]
  90. Řebíčková, K.; Bajer, T.; Šilha, D.; Houdková, M.; Ventura, K.; Bajerová, P. Chemical Composition and Determination of the Antibacterial Activity of Essential Oils in Liquid and Vapor Phases Extracted from Two Different Southeast Asian Herbs-Houttuynia Cordata (Saururaceae) and Persicaria Odorata (Polygonaceae). Molecules 2020, 25, 2432. [Google Scholar] [CrossRef]
  91. Verma, R.S.; Joshi, N.; Padalia, R.C.; Singh, V.R.; Goswami, P.; Kumar, A.; Iqbal, H.; Verma, R.K.; Chanda, D.; Chauhan, A.; et al. Chemical Composition and Allelopathic, Antibacterial, Antifungal, and Antiacetylcholinesterase Activity of Fish-Mint (Houttuynia cordataThunb.) from India. Chem. Biodivers. 2017, 14, e1700189. [Google Scholar] [CrossRef]
  92. Ng, A.W.T.; Poon, S.L.; Ni Huang, M.; Lim, J.Q.; Boot, A.; Yu, W.; Suzuki, Y.; Thangaraju, S.; Ng, C.C.Y.; Tan, P.; et al. Aristolochic Acids and Their Derivatives Are Widely Implicated in Liver Cancers in Taiwan and throughout Asia. Sci. Transl. Med. 2017, 9, eaan6446. [Google Scholar] [CrossRef]
  93. Du, S.; Li, H.; Cui, Y.; Yang, L.; Wu, J.; Huang, H.; Chen, Y.; Huang, W.; Zhang, R.; Yang, J.; et al. Houttuynia Cordata Inhibits Lipopolysaccharide-Induced Rapid Pulmonary Fibrosis by Up-Regulating IFN-γ and Inhibiting the TGF-β1/Smad Pathway. Int. Immunopharmacol. 2012, 13, 331–340. [Google Scholar] [CrossRef]
  94. Wu, Z.; Deng, X.; Hu, Q.; Xiao, X.; Jiang, J.; Ma, X.; Wu, M. Houttuynia cordata Thunb: An Ethnopharmacological Review. Front. Pharmacol. 2021, 12, 714694. [Google Scholar] [CrossRef]
  95. Bukovská, A.; Cikos, S.; Juhás, S.; Il’ková, G.; Rehák, P.; Koppel, J. Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice. Mediators Inflamm. 2007, 2007, 23296. [Google Scholar] [CrossRef]
  96. Ocaña, A.; Reglero, G. Effects of thyme extract oils (from Thymus vulgaris, Thymus zygis, and Thymus hyemalis) on cytokine production and gene expression of oxLDL-Stimulated THP-1-Macrophages. J. Obes. 2012, 2012, 104706. [Google Scholar] [CrossRef]
  97. Fachini-Queiroz, F.C.; Kummer, R.; Estevo-Silva, C.F.; de Carvalho, M.D.B.; Cunha, J.M.; Grespan, R.; Bersani-Amado, C.A.; Cuman, R.K.N. Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evid. Based Complement. Altern. Med. 2012, 2012, 657026. [Google Scholar] [CrossRef]
  98. Zhong, W.; Chi, G.; Jiang, L.; Soromou, L.W.; Chen, N.; Huo, M.; Guo, W.; Deng, X.; Feng, H. p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation 2012, 36, 529–537. [Google Scholar] [CrossRef] [PubMed]
  99. Gholijani, N.; Gharagozloo, M.; Kalantar, F.; Ramezani, A.; Amirghofran, Z. Modulation of cytokine production and transcription factors activities in human jurkat T cells by thymol and carvacrol. Adv. Pharm. Bull. 2015, 5, 653–660. [Google Scholar] [CrossRef] [PubMed]
  100. Abdelli, W.; Bahri, F.; Romane, A.; Höferl, M.; Wanner, J.; Schmidt, W.; Jirovetz, L. Chemical composition and anti-inflammatory activity of Algerian, T. vulgaris essential oil. Nat. Prod. Commun. 2017, 12, 611–614. [Google Scholar] [CrossRef] [PubMed]
  101. Tsai, M.-L.; Lin, C.-C.; Lin, W.-C.; Yang, C.-H. Antimicrobial, antioxidant, and anti-inflammatory activities of essential oils from five selected herbs. Biosci. Biotechnol. Biochem. 2011, 75, 1977–1983. [Google Scholar] [CrossRef]
  102. Abu-Darwish, M.S.; Cabral, C.; Gonçalves, M.J.; Cavaleiro, C.; Cruz, M.T.; Zulfiqar, A.; Khan, I.A.; Efferth, T.; Salgueiro, L. Chemical composition and biological activities of Artemisia judaica essential oil from southern desert of Jordan. J. Ethnopharmacol. 2016, 191, 161–168. [Google Scholar] [CrossRef]
  103. Benmansour, N.; Benmansour, A.; El Hanbali, F.; González-Mas, M.C.; Blázquez, M.A.; El Hakmaoui, A.; Akssira, M. Antimicrobial activity of essential oil of Artemisia judaica L. from Algeria against multi-drug resistant bacteria from clinical origin. Flavour Fragr. J. 2016, 31, 137–142. [Google Scholar] [CrossRef]
  104. Bora, K.S.; Sharma, A. The genus Artemisia: A comprehensive review. Pharm. Biol. 2011, 49, 101–109. [Google Scholar] [CrossRef] [PubMed]
  105. Al-Wahaibi, L.H.N.; Mahmood, A.; Khan, M.; Alkhathlan, H.Z. Comparative study on the essential oils of Artemisia judaica and A. herba-alba from Saudi Arabia. Arab. J. Chem. 2020, 13, 2053–2065. [Google Scholar] [CrossRef]
  106. Janacković, P.; Novaković, J.; Soković, M.; Vujisić, L.; Giweli, A.A.; Dajić-Stevanović, Z.; Marin, P.D. Composition and antimicrobial activity of essential oils of Artemisia judaica, A. herba-alba and A. arborescens from Libya. Arch. Biol. Sci. 2015, 67, 455–466. [Google Scholar] [CrossRef]
  107. Qu, N.; Xu, M.; Mizoguchi, I.; Furusawa, J.; Kaneko, K.; Watanabe, K.; Mizuguchi, J.; Itoh, M.; Kawakami, Y.; Yoshimoto, T. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin. Dev. Immunol. 2013, 2013, 96. [Google Scholar] [CrossRef]
  108. Bushiken, L.F.S.; Hussni, C.A.; Bastos, J.K.; Rozza, A.L.; Beserra, F.P.; Vieira, A.J.; Padovani, C.R.; Lemos, M.; Polizello Junior, M.; da Silva, J.J.M. Skin wound healing potential and mechanisms of the hydroalcoholic extract of leaves and oleoresin of Copaifera langsdorffii Desf. Kuntze in rats. Evid.-Based Complement. Altern. Med. 2017, 2017, 6589270. [Google Scholar] [CrossRef]
  109. Juergens, L.J.; Racké, K.; Tuleta, I.; Stoeber, M.; Juergens, U.R. Anti-inflammatory effects of 1, 8-cineole (eucalyptol) improve glucocorticoid effects in vitro: A novel approach of steroid-sparing add-on therapy for COPD and asthma? Synergy 2017, 5, 1–8. [Google Scholar] [CrossRef]
  110. Ehrnhöfer-Ressler, M.M.; Fricke, K.; Pignitter, M.; Walker, J.M.; Walker, J.; Rychlik, M.; Somoza, V. Identification of 1, 8-cineole, borneol, camphor, and thujone as anti-inflammatory compounds in a Salvia officinalis L. infusion using human gingival fibroblasts. J. Agric. Food Chem. 2013, 61, 3451–3459. [Google Scholar] [CrossRef]
  111. Leong, W.; Huang, G.; Liao, W.; Xia, W.; Li, X.; Su, Z.; Liu, L.; Wu, Q.; Kam Wai Wong, V.; Yuen Kwan Law, B.; et al. Traditional Patchouli essential oil modulates the host’s immune responses and gut microbiota and exhibits potent anti-cancer effects in ApcMin/+ mice. Pharmacol. Res. 2022, 176, 106082. [Google Scholar] [CrossRef]
  112. Sharifi-Rad, M.; Mnayer, D.; Morais-Braga, M.F.B.; Carneiro, J.N.P.; Bezerra, C.F.; Coutinho, H.D.M.; Salehi, B.; Martorell, M.; Contreras, M.d.M.; Soltani-Nejad, A.; et al. Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications. Phytother. Res. 2018, 32, 1653–1663. [Google Scholar] [CrossRef]
  113. Pellati, F.; Benvenuti, S.; Melegari, M.; Lasseigne, T. Variability in the composition of anti-oxidant compounds in Echinacea species by HPLC. Phytochem. Anal. 2005, 16, 77–85. [Google Scholar] [CrossRef]
  114. Mistrikova, I.; Vaverkova, S. Echinacea—Chemical composition, immunostimulatory activities and uses. Thaiszia J. Bot. 2006, 16, 11–26. [Google Scholar]
  115. Tan, B.K.; Vanitha, J. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: A review. Curr. Med. Chem. 2004, 11, 1423–1430. [Google Scholar] [CrossRef] [PubMed]
  116. Souissi, M.; Azelmat, J.; Chaieb, K.; Grenier, D. Antibacterial and anti-inflammatory activities of cardamom (Elettaria cardamomum) extracts: Potential therapeutic benefits for periodontal infections. Anaerobe 2020, 61, 102089. [Google Scholar] [CrossRef] [PubMed]
  117. Ashokkumar, K.; Murugan, M.; Dhanya, M.; Warkentin, T.D. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton]—A critical review. J. Ethnopharmacol. 2020, 246, 112244. [Google Scholar] [CrossRef]
  118. Bhattacharjee, B.; Chatterjee, J. Identification of proapoptopic, anti-inflammatory, anti-proliferative, anti-invasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pac. J. Cancer Prev. 2013, 14, 3735–3742. [Google Scholar] [CrossRef] [PubMed]
  119. Singh, G.; Kiran, S.; Marimuthu, P.; Isidorov, V.; Vinogorova, V. Antioxidant and antimicrobial activities of essential oil and various oleoresins of Elettaria cardamomum (seeds and pods). J. Sci. Food Agric. 2008, 88, 280–289. [Google Scholar] [CrossRef]
  120. Noumi, E.; Snoussi, M.; Alreshidi, M.M.; Rekha, P.-D.; Saptami, K.; Caputo, L.; De Martino, L.; Souza, L.F.; Msaada, K.; Mancini, E. Chemical and biological evaluation of essential oils from cardamom species. Molecules 2018, 23, 2818. [Google Scholar] [CrossRef]
  121. Backert, S.; Tegtmeyer, N.; Cróinín, T.Ó.; Boehm, M.; Heimesaat, M.M. Human campylobacteriosis. In Campylobacter; Klein, G., Ed.; Academic Press: Cambridge, MA, USA, 2017; pp. 1–25. [Google Scholar]
  122. Mutlu-Ingok, A.; Karbancioglu-Guler, F. Cardamom, Cumin, and Dill Weed Essential Oils: Chemical Compositions, Antimicrobial Activities, and Mechanisms of Action against Campylobacter spp. Molecules 2017, 22, 1191. [Google Scholar] [CrossRef]
  123. Friedman, M.; Henika, P.R.; Mandrell, R.E. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J. Food Prot. 2002, 65, 1545–1560. [Google Scholar] [CrossRef]
  124. Heimesaat, M.M.; Mousavi, S.; Weschka, D.; Bereswill, S. Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis. Microorganisms 2021, 9, 169. [Google Scholar] [CrossRef]
  125. Majdalawieh, A.F.; Carr, R.I. In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J. Med. Food 2010, 13, 371–381. [Google Scholar] [CrossRef] [PubMed]
  126. Yadav, N.; Chandra, H. Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1, 8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB. PLoS ONE 2017, 12, e0188232. [Google Scholar] [CrossRef] [PubMed]
  127. Nakamoto, A.; Goto, M.; Hasegawa, H.; Anzaki, C.; Nakamoto, M.; Shuto, E.; Sakai, T. Essential Oil of Citrus sudachi Suppresses T Cell Activation both in Vitro and in Vivo. J. Nutr. Sci. Vitaminol. 2022, 68, 513–520. [Google Scholar] [CrossRef] [PubMed]
  128. Shih, Y.S.; Tsai, C.H.; Li, T.C.; Yu, C.J.; Chou, J.W.; Feng, C.L.; Wang, K.T.; Lai, H.C.; Hsieh, C.L. Effect of wu chu yu tang on gastroesophagel reflux disease: Randomized, double-blind, placebo-controlled trial. Phytomedicine 2019, 56, 118–125. [Google Scholar] [CrossRef]
  129. Yeh, T.H.; Lin, J.Y. Acorus gramineusand and Euodia ruticarpa steam distilled essential oils exert anti-inflammatory effects through decreasing Th1/Th2 and pro-/anti-inflammatory cytokine secretion ratios in vitro. Biomolecules 2020, 10, 338. [Google Scholar] [CrossRef]
  130. Tai, S.; Sun, Y.; Squires, J.M.; Zhang, H.; Oh, W.E.; Liang, C.Z.; Huang, J. PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate 2011, 71, 1668–1679. [Google Scholar] [CrossRef]
  131. Santin, A.D.; Hermonat, P.L.; Ravaggi, A.; Bellone, S.; Pecorelli, S.; Roman, J.J.; Parham, G.P.; Cannon, M.J. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8+ cytotoxic T lymphocytes. J. Virol. 2000, 74, 4729–4737. [Google Scholar] [CrossRef]
  132. Li, X.; Lu, P.; Li, B.; Zhang, W.; Yang, R.; Chu, Y.; Luo, K. Interleukin 2 and interleukin 10 function synergistically to promote CD8+ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Int. J. Biochem. Cell Biol. 2017, 87, 1–7. [Google Scholar] [CrossRef]
  133. Trueblood, E.S.; Brown, W.C.; Palmer, G.H.; Davis, W.C.; Stone, D.M.; McElwain, T.F. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol. 1998, 72, 3169–3177. [Google Scholar] [CrossRef]
  134. Kirkwood, J.M.; Butterfield, L.H.; Tarhini, A.A.; Zarour, H.; Kalinski, P.; Ferrone, S. Immunotherapy of cancer in 2012. CA Cancer J. Clin. 2012, 62, 309–335. [Google Scholar] [CrossRef]
  135. Tahvildari, M.; Dana, R. Low-dose IL-2 therapy in transplantation, autoimmunity, and inflammatory diseases. J. Immunol. 2019, 203, 2749–2755. [Google Scholar] [CrossRef]
  136. Byard, R. Traditional medicine of aboriginal Australia. CMAJ 1988, 139, 792–794. [Google Scholar] [PubMed]
  137. Akhtar, M.A.; Raju, R.; Beattie, K.D.; Bodkin, F.; Munch, G. Medicinal plants of the Australian Aboriginal Dharawal people exhibiting anti-inflammatory activity. Evid.-Based Complement. Altern. Med. 2016, 2016, 2935403. [Google Scholar] [CrossRef] [PubMed]
  138. Mieres-Castro, D.; Ahmar, S.; Shabbir, R.; Mora-Poblete, F. Antiviral activities of eucalyptus essential oils: Their effectiveness as therapeutic targets against human viruses. Pharmaceuticals 2021, 14, 1210. [Google Scholar] [CrossRef] [PubMed]
  139. Dhakad, A.K.; Pandey, V.V.; Beg, S.; Rawat, J.M.; Singh, A. Biological, medicinal and toxicological significance of Eucalyptus leaf essential oil: A review. J. Sci. Food Agric. 2018, 98, 833–848. [Google Scholar] [CrossRef] [PubMed]
  140. Moreira, P.; Sousa, F.J.; Matos, P.; Brites, G.S.; Goncalves, M.J.; Cavaleiro, C.; Figueirinha, A.; Salgueiro, L.; Batista, M.T.; Branco, P.C.; et al. Chemical composition and effect against skin alterations of bioactive extracts obtained by the hydrodistillation of Eucalyptus globulus leaves. Pharmaceutics 2022, 14, 561. [Google Scholar] [CrossRef] [PubMed]
  141. Nakamura, T.; Yoshida, N.; Yamanoi, Y.; Honryo, A.; Tomita, H.; Kuwabara, H.; Kojima, Y. Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcepsilonRI signalling. Sci. Rep. 2020, 10, 20940. [Google Scholar] [CrossRef]
  142. Hendry, E.R.; Worthington, T.; Conway, B.R.; Lambert, P.A. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J. Antimicrob. Chemother. 2009, 64, 1219–1225. [Google Scholar] [CrossRef]
  143. Ben Hsouna, A.; Hamdi, N.; Miladi, R.; Abdelkafi, S. Myrtus communis Essential Oil: Chemical Composition and Antimicrobial Activities against Food Spoilage Pathogens. Chem. Biodivers. 2014, 11, 571–580. [Google Scholar] [CrossRef]
  144. Al-Maharik, N.; Jaradat, N.; Al-Hajj, N.; Jaber, S. Myrtus communis L.: Essential oil chemical composition, total phenols and flavonoids contents, antimicrobial, antioxidant, anticancer, and α-amylase inhibitory activity. Chem. Biol. Technol. Agric. 2023, 10, 41. [Google Scholar] [CrossRef]
  145. Yang, J.-K.; Choi, M.-S.; Seo, W.-T.; Rinker, D.L.; Han, S.W.; Cheong, G.-W. Chemical composition and antimicrobial activity of Chamaecyparis obtusa leaf essential oil. Fitoterapia 2007, 78, 149–152. [Google Scholar] [CrossRef] [PubMed]
  146. Eltayeb, L.M.H.; Yagi, S.; Mohamed, H.M.M.; Zengin, G.; Shariati, M.A.; Rebezov, M.; Uba, A.I.; Lorenzo, J.M. Essential Oils Composition and Biological Activity of Chamaecyparis obtusa, Chrysopogon nigritanus and Lavandula coronopifolia Grown Wild in Sudan. Molecules 2023, 28, 1005. [Google Scholar] [CrossRef]
  147. Hajhashemi, V.; Ghannadi, A.; Jafarabadi, H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother. Res. 2004, 18, 195–199. [Google Scholar] [CrossRef] [PubMed]
  148. Gerige, S.J.; Gerige, M.K.Y.; Rao, M. Ramanjaneyulu GC-MS analysis of Nigella sativa seeds and antimicrobial activity of its volatile oil. Braz. Arch. Biol. Technol. 2009, 52, 1189–1192. [Google Scholar] [CrossRef]
  149. Pan, X.; Li, H.; Chen, D.; Zheng, J.; Yin, L.; Zou, J.; Zhang, Y.; Deng, K.; Xiao, M.; Meng, L.; et al. Comparison of Essential Oils of Houttuynia cordata Thunb from Different Processing Methods and Harvest. Seasons Based on GC-MS and Chemometric Analysis. Int. J. Anal. Chem. 2021, 2021, 8324169. [Google Scholar] [CrossRef] [PubMed]
  150. Satyal, P.; Murray, B.L.; McFeeters, R.L.; Setzer, W.N. Essential Oil Characterization of Thymus vulgaris from Various Geographical Locations. Foods 2016, 5, 70. [Google Scholar] [CrossRef]
  151. Ermaya, D.; Sari, S.P.; Patria, A.; Hidayat, F.; Razi, F. Identification of patchouli oil chemical components as the results on distillation using GC-MS. IOP Conf. Ser. Earth Environ. Sci. 2019, 365, 012039. [Google Scholar] [CrossRef]
  152. Nyalambisa, M.; Oyemitan, I.A.; Matewu, R.; Oyedeji, O.O.; Oluwafemi, O.S.; Songca, S.P.; Nkeh-Chungag, B.N.; Oyedeji, A.O. Volatile constituents and biological activities of the leaf and root of Echinacea species from South Africa. Saudi Pharm. J. 2017, 25, 381–386. [Google Scholar] [CrossRef]
  153. Al-Zereini, W.A.; Al-Trawneh, I.N.; Al-Qudah, M.A.; TumAllah, H.M.; Al Rawashdeh, H.A.; Abudayeh, Z.H. Essential oils from Elettaria cardamomum (L.) Maton grains and Cinnamomum verum J. Presl barks: Chemical examination and bioactivity studies. J. Pharm. Pharmacogn. Res. 2022, 10, 173–185. [Google Scholar] [CrossRef]
  154. Akakabe, Y.; Sakamoto, M.; Ikeda, Y.; Tanaka, M. Identification and Characterization of Volatile Components of the Japanese Sour Citrus Fruit Citrus nagato-yuzukichi Tanaka. Biosci. Biotechnol. Biochem. 2008, 72, 1965–1968. [Google Scholar] [CrossRef]
  155. Hamada, T.; Harano, K.; Niihara, R.; Kitahara, H.; Yamamoto, M.; Vairrapan, C.S.; Tani, F.; Onitsuka, S.; Okamura, H. Composition and Monthly Changes of the Volatile Constituents in the Sour Hetsuka-daidai Citrus Peel. J. Oleo Sci. 2000, 69, 643–648. [Google Scholar] [CrossRef] [PubMed]
  156. Yang, J.; Wang, Q.; Li, L.; Li, P.; Yin, M.; Xu, S.; Chen, Y.; Feng, X.; Wang, B. Chemical Composition and Antifungal Activity of Zanthoxylum armatum Fruit Essential Oil against Phytophthora capsici. Molecules 2022, 27, 8636. [Google Scholar] [CrossRef] [PubMed]
  157. Almas, I.; Innocent, E.; Machumi, F.; Kisinza, W. Chemical composition of essential oils from Eucalyptus globulus and Eucalyptus maculata grown in Tanzania. Sci. Afr. 2021, 12, e00758. [Google Scholar] [CrossRef]
  158. Schepetkin, I.A.; Kushnarenko, S.V.; Özek, G.; Kirpotina, L.N.; Sinharoy, P.; Utegenova, G.A.; Abidkulova, K.T.; Özek, T.; Başer, K.H.; Kovrizhina, A.R.; et al. Modulation of Human Neutrophil Responses by the Essential Oils from Ferula akitschkensis and Their Constituents. J. Agric. Food Chem. 2016, 38, 7156–7170. [Google Scholar] [CrossRef]
  159. Nam, S.Y.; Chung, C.K.; Seo, J.H.; Rah, S.Y.; Kim, H.M.; Jeong, H.J. The therapeutic efficacy of alpha-pinene in an experimental mouse model of allergic rhinitis. Int. Immunopharmacol. 2014, 23, 273–282. [Google Scholar] [CrossRef] [PubMed]
  160. Schepetkin, I.A.; Kushnarenko, S.V.; Ozek, G.; Kirpotina, L.N.; Utegenova, G.A.; Kotukhov, Y.A.; Danilova, A.N.; Ozek, T.; Baser, K.H.; Quinn, M.T. Inhibition of human neutrophil responses by the essential oil of Artemisia kotuchovii and its constituents. J. Agric. Food. Chem. 2015, 63, 4999–5007. [Google Scholar] [CrossRef]
  161. Kim, D.S.; Lee, H.J.; Jeon, Y.D.; Han, Y.H.; Kee, J.Y.; Kim, H.J.; Shin, H.J.; Kang, J.; Lee, B.S.; Kim, S.H.; et al. Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages. Am. J. Chin. Med. 2015, 4, 731–742. [Google Scholar] [CrossRef]
  162. Li, X.J.; Yang, Y.J.; Li, Y.S.; Zhang, W.K.; Tang, H.B. alpha-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2. J. Ethnopharmacol. 2016, 179, 22–26. [Google Scholar] [CrossRef]
  163. Kazemi, M. Phytochemical Composition, Antioxidant, Anti-inflammatory and Antimicrobial Activity of Nigella sativa L. J. Essent. Oil Bear. Plants 2014, 17, 1002–1011. [Google Scholar] [CrossRef]
  164. Vieira, A.J.; Beserra, F.P.; Souza, M.C.; Totti, B.M.; Rozza, A.L. Limonene: Aroma of innovation in health and disease. Sens. Actuators A Phys. 2000, 83, 47–53. [Google Scholar] [CrossRef]
  165. Rufino, A.T.; Ribeiro, M.; Sousa, C.; Judas, F.; Salgueiro, L.; Cavaleiro, C.; Mendes, A.F. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur. J. Pharmacol. 2015, 750, 141–150. [Google Scholar] [CrossRef] [PubMed]
  166. Yoon, W.; Lee, N.; Hyun, C. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2 and pro-inflammatory cytokines in RAW 264.7 macrophages. J. Oleo Sci. 2010, 59, 415–421. [Google Scholar] [CrossRef]
  167. Lee, J.H.; Chang, K.M.; Kim, G.H. Composition and anti-inflammatory activities of Zanthoxylum schinifolium essential oil: Suppression of inducible nitric oxide synthase, cyclooxygenase-2, cytokines and cellular adhesion. J. Sci. Food Agric. 2009, 89, 1762–1769. [Google Scholar] [CrossRef]
  168. Miguel, M.G. Antioxidant and Anti-Inflammatory Activities of Essential Oils: A Short Review. Molecules 2010, 15, 9252–9287. [Google Scholar] [CrossRef] [PubMed]
  169. Vogt-Eisele, A.K.; Weber, K.; Sherkheli, M.A.; Vielhaber, G.; Panten, J.; Gisselmann, G.; Hatt, H. Monoterpenoid agonists of TRPV3. Br. J. Pharmacol. 2007, 151, 530–540. [Google Scholar] [CrossRef]
  170. Vonapart, A.; Karioti, A.; Recio, M.C.; Máñez, S.; Ríos, J.L.; Skaltsa, E.; Giner, R.M. Effects of Terpenoids from Salvia willeana in Delayed-type Hypersensitivity, Human Lymphocyte Proliferation and Cytokine Production. Nat. Prod. Commun. 2008, 3, 1953–1958. [Google Scholar] [CrossRef]
  171. Islam, A.U.S.; Hellman, B.; Nyberg, F.; Amir, N.; Jayaraj, R.L.; Petroianu, G.; Adem, A. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat. Model. Molecules 2020, 25, 4492. [Google Scholar] [CrossRef]
  172. Schepetkin, I.A.; Özek, G.; Özek, T.; Kirpotina, L.N.; Khlebnikov, A.I.; Quinn, M.T. Chemical Composition and Immunomodulatory Activity of Essential Oils from Rhododendron albiflorum. Molecules 2021, 26, 3652. [Google Scholar] [CrossRef]
  173. Kawata, J.; Kameda, M.; Miyazawa, M. Cyclooxygenase-2 inhibitory effects of monoterpenoids with a p-methane skeleton. Int. J. Essent. Oil Ther. 2008, 2, 145–148. [Google Scholar]
  174. Held, S.; Schieberle, P.; Somoza, V. Characterization of alpha-terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. J. Agric. Food Chem. 2007, 55, 8040–8046. [Google Scholar] [CrossRef]
  175. Siqueira, H.D.S.; Neto, B.S.; Sousa, D.P.; Gomes, B.S.; da Silva, F.V.; Cunha, F.V.M.; Wanderley, C.W.S.; Pinheiro, G.; Cândido, A.G.F.; Wong, D.V.T.; et al. α-Phellandrene, a cyclic monoterpene, attenuates inflammatory response through neutrophil migration inhibition and mast cell degranulation. Life Sci. 2016, 160, 27–33. [Google Scholar] [CrossRef] [PubMed]
  176. Oliveira, M.G.; Marques, R.B.; Santana, M.F.; Santos, A.B.; Brito, F.A.; Barreto, E.O.; Sousa, D.P.; Almeida, F.R.; Badauê-Passos, D.; Antoniolli, A.R.; et al. α-Terpineol reduces mechanical hypernociception and inflammatory response. Basic Clin. Pharmacol. Toxicol. 2012, 2, 120–125. [Google Scholar] [CrossRef]
  177. Apel, M.; Lima, M.E.L.; Sobral, M.; Young, M.C.C.; Cordeiro, I.; Schapoval, E.E.S.; Henriques, A.T.; Moreno, P.R.H. Anti-inflammatory activity of essential oil from leaves of Myciaria tenella and Calycorectes sellowianus. Pharm. Biol. 2010, 4, 433–438. [Google Scholar] [CrossRef] [PubMed]
  178. Sen, A.; Kurkcuoglu, M.; Yildirim, A.; Senkardes, I.; Bitis, L.; Baser, K.H.C. Chemical composition, antiradical, and enzyme inhibitory potential of essential oil obtained from aerial part of Centaureapterocaula Trautv. J. Essent. Oil Res. 2020, 33, 44–52. [Google Scholar] [CrossRef]
  179. Ziaei, A.; Ramezani, M.; Wright, L.; Paetz, C.; Schneider, B.; Amirghofran, Z. Identification of spathulenol in Salvia mirzayanii and the immunomodulatory effects. Phytother. Res. 2011, 25, 557–562. [Google Scholar] [CrossRef] [PubMed]
  180. Chao, L.K.; Hua, K.F.; Hsu, H.Y.; Cheng, S.S.; Liu, J.Y.; Chang, S.T. Study on the antiinflammatory activity of essential oil from leaves of Cinnamomum osmophloeum. J. Agric. Food Chem. 2005, 53, 7274–7278. [Google Scholar] [CrossRef]
  181. Kim, C.; Cho, S.K.; Kim, K.D.; Nam, D.; Chung, W.S.; Jang, H.J.; Lee, S.G.; Shim, B.S.; Sethi, G.; Ahn, K.S. β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NFκB-regulated gene products. Apoptosis 2014, 19, 708–718. [Google Scholar] [CrossRef]
  182. Silva, R.O.; Salvadori, M.S.; Sousa, F.B.M.; Santos, M.S.; Carvalho, N.S.; Sousa, D.P.; Gomes, B.S.; Oliveira, F.A.; Barbosa, A.L.R.; Freitas, R.M.; et al. Evaluation of the anti-inflammatory and antinociceptive effects of myrtenol, a plant-derived monoterpene alcohol, in mice. Flavour Fragr. J. 2014, 29, 184–192. [Google Scholar] [CrossRef]
  183. Yoon, W.J.; Kim, S.S.; Oh, T.H.; Lee, N.H.; Hyun, C.G. Cryptomeria japonica essential oil ninhibits the growth of drug-resistant skin pathogens and LPS-induced NO and pro-inflammatory cytokine production. Pol. J. Microbiol. 2009, 58, 61–68. [Google Scholar]
  184. Valente, J.; Zuzarte, M.; Gonçalves, M.J.; Lopes, M.C.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil. Food Chem. Toxicol. 2013, 62, 349–354. [Google Scholar] [CrossRef]
  185. Schepetkin, I.A.; Ozek, G.; Ozek, T.; Kirpotina, L.N.; Kokorina, P.I.; Khlebnikov, A.I.; Quinn, M.T. Neutrophil Immunomodulatory activity of nerolidol, a major component of essential oils from Populus balsamifera buds and propolis. Plants 2022, 11, 3399. [Google Scholar] [CrossRef] [PubMed]
  186. Hart, P.; Brand, C.; Carson, C.; Riley, T.V.; Prager, R.H.; Finlay-Jones, J.J. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 2000, 49, 619–626. [Google Scholar] [CrossRef] [PubMed]
  187. Nogueira, M.N.M.; Aquino, S.G.; Rossa Junior, C.; Spolidorio, D.M. Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages. Inflamm. Res. 2014, 63, 769–778. [Google Scholar] [CrossRef]
  188. De Christo Scherer, M.M.; Marques, F.M.; Figueira, M.M.; Peisino, M.C.O.; Schmitt, E.F.P.; Kondratyuk, T.P.; Endringer, D.C.; Scherer, R.; Fronza, M. Wound healing activity of terpinolene and α-phellandrene by attenuating inflammation and oxidative stress in vitro. J. Tissue Viability 2019, 2, 94–99. [Google Scholar] [CrossRef] [PubMed]
  189. Carrera-Martínez, C.A.; Rosas-López, R.; Rodríguez-Monroy, M.A.; Canales-Martínez, M.M.; Román-Guerrero, A.; Jiménez-Alvarado, R. Chemical composition and in vivo anti-inflammatory activity of Bursera morelensis Ramírez essential oil. J. Essent. Oil Bear. Plants 2014, 17, 758–768. [Google Scholar]
  190. Fonsêca, D.V.; Salgado, P.R.; de Carvalho, F.L.; Salvadori, M.G.; Penha, A.R.; Leite, F.C.; Borges, C.J.; Piuvezam, M.R.; Pordeus, L.C.; Sousa, D.P.; et al. Nerolidol exhibits antinociceptive and anti-inflammatory activity: Involvement of the GABAergic system and proinflammatory cytokines. Fundam. Clin. Pharmacol. 2016, 1, 14–22. [Google Scholar] [CrossRef]
  191. Javed, H.; Azimullah, S.; Abul Khair, S.B.; Ojha, S.; Haque, M.E. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone. BMC Neurosci. 2016, 17, 58. [Google Scholar] [CrossRef]
  192. Gomes, B.S.; Neto, B.P.; Lopes, E.M.; Cunha, F.V.; Araújo, A.R.; Wanderley, C.W.; Wong, D.V.; Júnior, R.C.P.; Ribeiro, R.A.; Sousa, D.P.; et al. Anti-inflammatory effect of the monoterpene myrtenol is dependent on the direct modulation of neutrophil migration and oxidative stress. Chem.-Biol. Interact. 2017, 273, 73–81. [Google Scholar] [CrossRef]
  193. Yang, H.; Zhao, R.; Chen, H.; Jia, P.; Bao, L.; Tang, H. Bornyl acetate has an anti-inflammatory effect in human chondrocytes via induction of IL-11. IUBMB Life 2014, 66, 854–859. [Google Scholar] [CrossRef]
  194. Yang, L.; Liu, J.; Li, Y.; Qi, G. Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells. Biomed. Pharmacother. 2018, 103, 234–239. [Google Scholar] [CrossRef]
  195. Chen, N.; Sun, G.; Yuan, X.; Hou, J.; Wu, Q.; Soromou, L.W.; Feng, H. Inhibition of lung inflammatory responses by bornyl acetate is correlated with regulation of myeloperoxidase activity. J. Surg. Res. 2014, 1, 436–445. [Google Scholar] [CrossRef]
  196. Zhao, Z.J.; Sun, Y.I.; Ruan, X. Bornyl Acetate: A Promising Agent In Phytomedicine for Inflammation and Immune Modulation. Phytomedicine 2023, 114, 154781. [Google Scholar] [CrossRef]
  197. Singh, S.; Singh, T.G.; Mahajan, K.; Dhiman, S. Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis. J. Pharm. Pharmacol. 2020, 72, 1306–1327. [Google Scholar] [CrossRef]
  198. Juergens, U.R.; Engelen, T.; Racke, K.; Stober, M.; Gillissen, A.; Vetter, H. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes Pulm. Pharmacol. Ther. 2004, 17, 281. [Google Scholar]
  199. Ashrafizadeh, M.; Ahmadi, Z.; Mohammadinejad, R.; Kaviyani, N.; Tavako, S. Monoterpenes modulating autophagy: A review study. Basic Clin. Pharmacol. Toxicol. 2020, 126, 9–20. [Google Scholar] [CrossRef]
  200. Horváth, G.; Horváth, A.; Reichert, G.; Böszörményi, A.; Sipos, K.; Pandur, E. Three chemotypes of thyme (Thymus vulgaris L.) essential oil and their main compounds affect differently the IL-6 and TNFα cytokine secretions of BV-2 microglia by modulating the NF-κB and C/EBPβ signalling pathways. BMC Complement. Med. Ther. 2021, 1, 148. [Google Scholar] [CrossRef]
  201. De Santana, M.F.; Guimarães, A.G.; Chaves, D.O.; Silva, J.C.; Bonjardim, L.R.; de Lucca Júnior, W.; Ferro, J.N.; Barreto Ede, O.; dos Santos, F.E.; Soares, M.B.; et al. The anti-hyperalgesic and anti-inflammatory profiles of p-cymene: Evidence for the involvement of opioid system and cytokines. Pharm. Biol. 2015, 11, 1583–1590. [Google Scholar] [CrossRef]
  202. Xie, G.; Chen, N.; Soromou, L.W.; Liu, F.; Xiong, Y.; Wu, Q.; Li, H.; Feng, H.; Liu, G. p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 2012, 7, 8159–8173. [Google Scholar] [CrossRef]
  203. Pries, R.; Jeschke, S.; Leichtle, A.; Bruchhage, K.L. Modes of Action of 1,8-Cineol in Infections and Inflammation. Metabolites 2023, 6, 751. [Google Scholar] [CrossRef]
  204. Juergens, U.R.; Stober, M.; Vetter, H. Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1,8- cineole) in human monocytes in vitro. Eur. J. Med. Res. 1998, 3, 508–510. [Google Scholar]
  205. Greiner, J.F.; Müller, J.; Zeuner, M.T.; Hauser, S.; Seidel, T.; Klenke, C.; Grunwald, L.M.; Schomann, T.; Widera, D.; Sudhoff, H.; et al. 1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity. Biochim. Biophys. Acta 2013, 12, 2866–2878. [Google Scholar] [CrossRef]
  206. Li, Y.; Lai, Y.; Wang, Y.; Liu, N.; Zhang, F.; Xu, P. 1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice. Inflammation 2016, 4, 1582–1593. [Google Scholar] [CrossRef]
  207. Rui, Y.; Han, X.; Han, A.; Hu, J.; Li, M.; Liu, B.; Qian, F.; Huang, L. Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. Eur. J. Pharmacol. 2022, 931, 175184. [Google Scholar] [CrossRef]
  208. Chang, M.Y.; Shen, Y.L. Linalool exhibits cytotoxic effects by activating antitumor immunity. Molecules 2014, 5, 6694–6706. [Google Scholar] [CrossRef]
  209. Su, Y.W.; Chao, S.H.; Lee, M.H.; Ou, T.Y.; Tsai, Y.C. Inhibitory effects of citronellol and geraniol on nitric oxide and prostaglandin E2 production in macrophages. Planta Med. 2010, 76, 1666–1671. [Google Scholar] [CrossRef]
  210. Mikami, T.; Miyasaka, K. Effects of several anti-inflammatory drugs on the various parameters involved in the inflammatory response in rat carrageenin-induced pleurisy. Eur. J. Pharmacol. 1983, 95, 1–12. [Google Scholar] [CrossRef]
  211. Sousa, G.M.; Cazarin, C.B.B.; Marostica Junior, M.R.; Lamas, C.A.; Quitete, V.H.A.C.; Pastore, G.M.; Bicas, J.L. The effect of α-terpineol enantiomers on biomarkers of rats fed a high fat-diet. Heliyon Food Sci. 2020, 4, e03752. [Google Scholar] [CrossRef]
  212. Khaleel, C.; Nurhayat, T.; Gerhard, B. α-Terpineol, a natural monoterpene: A review of its biological properties. Open Chem. 2018, 16, 349–361. [Google Scholar] [CrossRef]
  213. Trinh, H.T.; Lee, I.A.; Hyun, Y.J.; Kim, D.H. Artemisia princepsPamp. Essential Oil and Its Constituents Eucalyptol andα-terpineol Ameliorate Bacterial Vaginosis and Vulvovaginal Candidiasis in Mice by Inhibiting Bacterial Growth and NF-κB Activation. Planta Medica 2011, 18, 1996–2002. [Google Scholar] [CrossRef]
  214. da Silva Lima, M.; Quintans-Junior, L.J.; de Santana, W.A.; Martins Kaneto, C.; Botelho Pereira Soares, M.; Villarreal, C.F. Anti-inflammatory effects of carvacrol: Evidence for a key role of interleukin-10. Eur. J. Pharmacol. 2013, 699, 112–117. [Google Scholar] [CrossRef]
  215. Nemmar, A.; Al-Salam, S.; Zia, S.; Marzouqi, F.; Al-Dhaheri, A.; Subramaniyan, D.; Dhanasekaran, S.; Yasin, J.; Ali, B.H.; Kazzam, E.E. Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone. Br. J. Pharmacol. 2011, 164, 1871–1882. [Google Scholar] [CrossRef] [PubMed]
  216. Ammar, E.S.M.; Gameil, N.M.; Shawky, N.M.; Nader, M.A. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. Int. Immunopharmacol. 2011, 11, 2232–2236. [Google Scholar] [CrossRef] [PubMed]
  217. Umar, S.; Zargan, J.; Umar, K.; SAhmad, S.; Katiyar, C.K.; Khan, H.A. Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats. Chem. Biol. Interact. 2012, 197, 40–46. [Google Scholar] [CrossRef]
  218. El Gazzar, M.; El Mezayen, R.; Nicolls, M.R.; Marecki, J.C.; Dreskin, S.C. Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Biochim. Biophys. Acta Gen. Subj. 2006, 1760, 1088–1095. [Google Scholar] [CrossRef] [PubMed]
  219. Kohandel, Z.; Farkhondeh, T.; Aschner, M.; Samarghandian, S. Anti-inflammatory effects of thymoquinone and its protective effects against several diseases. Biomed. Pharmacother. 2021, 138, 111492. [Google Scholar] [CrossRef] [PubMed]
  220. El Mezayen, R.; El Gazzar, M.; Nicolls, M.R.; Marecki, J.C.; Dreskin, S.C.; Nomiyama, H. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol. Lett. 2006, 1, 72–81. [Google Scholar] [CrossRef]
  221. Al Wafai, R.J. Nigella Sativa and thymoquinone suppress cyclooxygenase-2 and oxidative stress in pancreatic tissue of streptozotocin-induced diabetic rats. Pancreas 2013, 42, 841–849. [Google Scholar] [CrossRef]
  222. Kundu, J.K.; Liu, L.; Shin, J.W.; Surh, Y.J. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo. Biochem. Biophys. Res. Commun. 2013, 438, 721–727. [Google Scholar] [CrossRef]
Figure 1. Immunomodulatory and anti-inflammatory properties of essential oils. Created with Biorender.com (↑ stimulation, ↓ reduction).
Figure 1. Immunomodulatory and anti-inflammatory properties of essential oils. Created with Biorender.com (↑ stimulation, ↓ reduction).
Biomedicines 11 02381 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Grazul, M.; Kwiatkowski, P.; Hartman, K.; Kilanowicz, A.; Sienkiewicz, M. How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters. Biomedicines 2023, 11, 2381. https://doi.org/10.3390/biomedicines11092381

AMA Style

Grazul M, Kwiatkowski P, Hartman K, Kilanowicz A, Sienkiewicz M. How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters. Biomedicines. 2023; 11(9):2381. https://doi.org/10.3390/biomedicines11092381

Chicago/Turabian Style

Grazul, Magdalena, Paweł Kwiatkowski, Kacper Hartman, Anna Kilanowicz, and Monika Sienkiewicz. 2023. "How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters" Biomedicines 11, no. 9: 2381. https://doi.org/10.3390/biomedicines11092381

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop